糖脂平对高脂诱导胰岛素抵抗大鼠脂肪因子与蛋白激酶B的影响
|
摘要
本论文共分为两个部分:胰岛素抵抗的文献综述和中药糖脂平干预胰岛素抵抗的实验研究部分。
1文献研究
本论文文献综述分两个部分,即中医文献研究和现代医学研究进展两部分。中医文献从中医对胰岛素抵抗的病因病机和辩证分型以及临床治疗与实验研究等方面,进行了系统的评述;现代医学综述研究系统回顾了近十几年来国内外对胰岛素抵抗的发病机制以及药物治疗进展方面的进展情况进行了系统的总结和综述。
2实验研究
目的
本研究在糖脂平干预糖耐量低减(IGT),改善胰岛素抵抗疗效确切的基础上,采用细胞分子生物学技术,探讨糖脂平对脂肪细胞因子(脂联素、肿瘤坏死因子)及胰岛素受体传导通路中蛋白激酶B(PKB/Akt)基因表达的影响,阐明糖脂平改善胰岛素抵抗的作用靶点和途径,为中医药改善胰岛素抵抗提供科学依据。
方法
采用高脂喂养的方法建立诱发胰岛素抵抗大鼠模型。将符合条件的SD大鼠随机分为4组(正常组、模型组、糖脂平组、罗格列酮组),每组10只。中药组给予糖脂平10ml/kg/d(生药20g/kg/d)灌胃;西药组给予文迪亚0.8mg/kg/d灌胃8周;采用胰岛素抵抗评价“金标准”正常葡萄糖钳夹技术,评价糖脂平对胰岛素抵抗大鼠胰岛素敏感性及糖脂代谢的影响;采用RT-PCR技术观察了糖脂平对胰岛素抵抗大鼠脂肪细胞因子(脂联素、肿瘤坏死因子)及胰岛素受体传导通路中蛋白激酶B(PKB/Akt)基因表达的影响。
结果
1高脂诱导的大鼠模型,与正常对照组比较具有体重增加、血糖升高、空腹胰岛素升高、脂代谢紊乱、葡萄糖输注率(GIR)显著降低等特征,表现出明显的胰岛素抵抗,符合人类胰岛素抵抗的发病特点,是比较理想的胰岛素抵抗动物模型。
2糖脂平与罗格列酮均可升高葡萄糖输注率(GIR)M值(P＜0.05、P＜0.01),均可降低空腹血糖、空腹胰岛素、降低TC、LDL-C(P＜0.05),可降低胰岛素抵抗模型大鼠体重(P＜0.05)。
3高脂诱导的大鼠模型组与正常对照组比较,附睾脂肪组织脂联素mRNA表达显著降低(P＜0.01),糖脂平与罗格列酮均可上调高脂诱导的大鼠附睾脂肪组织脂联素mRNA表达(P＜0.05、P＜0.01)。
4高脂诱导的大鼠模型组与正常对照组比较,附睾脂肪组织肿瘤坏死因子mRNA表达显著增强(P＜0.05),糖脂平与罗格列酮均可下调高脂诱导的大鼠附睾脂肪组织肿瘤坏死因子mRNA表达(P＜0.05、P＜0.01)。
5高脂诱导的大鼠模型组与正常对照组比较,附睾脂肪组织与骨骼肌组织蛋白激酶B mRNA表达显著降低(P＜0.05),糖脂平与罗格列酮均可明显上调附睾脂肪这种和骨骼肌组织蛋白激酶B mRNA表达(P＜0.05)。
结论
糖脂平可降低胰岛素抵抗模型大鼠葡萄糖输注率(GIR)M值,改善胰岛素抵抗;降低胰岛素抵抗模型大鼠体重、改善糖脂代谢紊乱;可上调胰岛素抵抗模型大鼠脂肪组织脂联素mRNA基因表达;下调胰岛素抵抗模型大鼠脂肪组织肿瘤坏死因子基因表达;可上调胰岛素抵抗模型大鼠脂肪组织及骨骼肌组织蛋白激酶B mRNA基因表达。糖脂平可能通过影响脂肪组织的脂联素、肿瘤坏死因子及脂肪与肌肉组织蛋白激酶B基因表达,而发挥改善胰岛素抵抗的作用。
There are two parts in this thesis:Reference review of insulin resistance (IR),and experimental study on the prevention and treatment for IR by Tangzhiping.
1 reference review
This essay reviewed from the advances of such fields as followed:reference review of Chinese medicine and modern medicine research.We had a systematic discussion from the pathogenesis theory,syndrome differentiation,and clinical and experimental study for IR with Chinese medicine.At the sametime,we reviewed the pathogenesis and progressof drugs for IR in modern medicine systematically.
2 experimental study
Objectives
Based on the prevention and treatment for IGT,and improving IR with Tangzhiping, we investigated the influence of Tangzhiping on the gene expression of adiposederived cell factor and insulin signaling pathway in T2DM and IR,in order to supply the basic theory and experimental data for researching the mechanism of action of the function of the adiposity in IR and T2DM and for the mechanism of action of Tangzhiping.
Methods
Weused IR rats model by high fat,and divided them randomly into four groups: normal group,model group,rosiglitazone group,TZP groups.Every group included 10 rats;fat forage induced insulin rat were used as animal models.Model group and normal group were intragastric administrated with sterile water;western medicine group were intragastric administrated with rosiglitazone,and TZP groups were intragastric administrated with TZP separately.After treated correspondingly separately for 8 weeks,general condition were observed in all groups, hyper insulin mice uglycemic clamp were used for evaluate IR.All mice werekilled to collect the blood,adipocyte and the muscle.Adiponectin,TNF-α,leptin, PKB/Akt was detected by RT-PCR.
Results
1.Rats model induced by high fat had elevatory body weight,blood sugar and fasting insulin,and had a characteristics of lipid metabolism disorder,the descending of glucose metabolic rate.So this model is comparatively ideal IR animal model.
2.TZP and rosiglitazone could increased glucose infusion rate(M)(P＜0.05、P＜0.01),and could decreased fasting blood glucose and serum insulin、TC、LDL-C (P＜0.05),decreased the body weight of IR model rats.
3.Rats model induced by high fat had elevatory adiponcetin mRNA levels in the epididymis(P＜0.05、P＜0.01),which ramarkable reduce than normal groups. TZP and rosiglitazone could increased adiponcetin mRNA levels in the epididymis (P＜0.05、P＜0.01).
4.Rats model induced by high fat had descending TNF mRNA levels in the epididymis(P＜0.05、P＜0.01),which ramarkable reduce than normal groups.TZP and rosiglitazone could decreased TNF mRNA levels in the epididymis(P＜0.05、P＜0.01).
5.Rats model induced by high fat had elevatory PKB mRNA levels in the epididymis and skeletal muscle(P＜0.05、P＜0.01),which ramarkable reduce than normal groups.TZP and rosiglitazone could increased leptin mRNA levels in the epididymis and skeletal muscle(P＜0.05、P＜0.01).
conclusion
TZP could descended glucose infusion rate(M),improving IR;descended the body weight and improved lipid metabolism disorder of IR model rats;increased adiponcetin mRNA levels in the epididymis;decreased TNF mRNA and levels in the epididymis;increased leptin mRNA levels in the epididymis and skeletal muscle. So TZP have a role of improving IR through effecting the expression of adiponcetin、TNF、liptin and PKB.
1文献研究
本论文文献综述分两个部分,即中医文献研究和现代医学研究进展两部分。中医文献从中医对胰岛素抵抗的病因病机和辩证分型以及临床治疗与实验研究等方面,进行了系统的评述;现代医学综述研究系统回顾了近十几年来国内外对胰岛素抵抗的发病机制以及药物治疗进展方面的进展情况进行了系统的总结和综述。
2实验研究
目的
本研究在糖脂平干预糖耐量低减(IGT),改善胰岛素抵抗疗效确切的基础上,采用细胞分子生物学技术,探讨糖脂平对脂肪细胞因子(脂联素、肿瘤坏死因子)及胰岛素受体传导通路中蛋白激酶B(PKB/Akt)基因表达的影响,阐明糖脂平改善胰岛素抵抗的作用靶点和途径,为中医药改善胰岛素抵抗提供科学依据。
方法
采用高脂喂养的方法建立诱发胰岛素抵抗大鼠模型。将符合条件的SD大鼠随机分为4组(正常组、模型组、糖脂平组、罗格列酮组),每组10只。中药组给予糖脂平10ml/kg/d(生药20g/kg/d)灌胃;西药组给予文迪亚0.8mg/kg/d灌胃8周;采用胰岛素抵抗评价“金标准”正常葡萄糖钳夹技术,评价糖脂平对胰岛素抵抗大鼠胰岛素敏感性及糖脂代谢的影响;采用RT-PCR技术观察了糖脂平对胰岛素抵抗大鼠脂肪细胞因子(脂联素、肿瘤坏死因子)及胰岛素受体传导通路中蛋白激酶B(PKB/Akt)基因表达的影响。
结果
1高脂诱导的大鼠模型,与正常对照组比较具有体重增加、血糖升高、空腹胰岛素升高、脂代谢紊乱、葡萄糖输注率(GIR)显著降低等特征,表现出明显的胰岛素抵抗,符合人类胰岛素抵抗的发病特点,是比较理想的胰岛素抵抗动物模型。
2糖脂平与罗格列酮均可升高葡萄糖输注率(GIR)M值(P＜0.05、P＜0.01),均可降低空腹血糖、空腹胰岛素、降低TC、LDL-C(P＜0.05),可降低胰岛素抵抗模型大鼠体重(P＜0.05)。
3高脂诱导的大鼠模型组与正常对照组比较,附睾脂肪组织脂联素mRNA表达显著降低(P＜0.01),糖脂平与罗格列酮均可上调高脂诱导的大鼠附睾脂肪组织脂联素mRNA表达(P＜0.05、P＜0.01)。
4高脂诱导的大鼠模型组与正常对照组比较,附睾脂肪组织肿瘤坏死因子mRNA表达显著增强(P＜0.05),糖脂平与罗格列酮均可下调高脂诱导的大鼠附睾脂肪组织肿瘤坏死因子mRNA表达(P＜0.05、P＜0.01)。
5高脂诱导的大鼠模型组与正常对照组比较,附睾脂肪组织与骨骼肌组织蛋白激酶B mRNA表达显著降低(P＜0.05),糖脂平与罗格列酮均可明显上调附睾脂肪这种和骨骼肌组织蛋白激酶B mRNA表达(P＜0.05)。
结论
糖脂平可降低胰岛素抵抗模型大鼠葡萄糖输注率(GIR)M值,改善胰岛素抵抗;降低胰岛素抵抗模型大鼠体重、改善糖脂代谢紊乱;可上调胰岛素抵抗模型大鼠脂肪组织脂联素mRNA基因表达;下调胰岛素抵抗模型大鼠脂肪组织肿瘤坏死因子基因表达;可上调胰岛素抵抗模型大鼠脂肪组织及骨骼肌组织蛋白激酶B mRNA基因表达。糖脂平可能通过影响脂肪组织的脂联素、肿瘤坏死因子及脂肪与肌肉组织蛋白激酶B基因表达,而发挥改善胰岛素抵抗的作用。
There are two parts in this thesis:Reference review of insulin resistance (IR),and experimental study on the prevention and treatment for IR by Tangzhiping.
1 reference review
This essay reviewed from the advances of such fields as followed:reference review of Chinese medicine and modern medicine research.We had a systematic discussion from the pathogenesis theory,syndrome differentiation,and clinical and experimental study for IR with Chinese medicine.At the sametime,we reviewed the pathogenesis and progressof drugs for IR in modern medicine systematically.
2 experimental study
Objectives
Based on the prevention and treatment for IGT,and improving IR with Tangzhiping, we investigated the influence of Tangzhiping on the gene expression of adiposederived cell factor and insulin signaling pathway in T2DM and IR,in order to supply the basic theory and experimental data for researching the mechanism of action of the function of the adiposity in IR and T2DM and for the mechanism of action of Tangzhiping.
Methods
Weused IR rats model by high fat,and divided them randomly into four groups: normal group,model group,rosiglitazone group,TZP groups.Every group included 10 rats;fat forage induced insulin rat were used as animal models.Model group and normal group were intragastric administrated with sterile water;western medicine group were intragastric administrated with rosiglitazone,and TZP groups were intragastric administrated with TZP separately.After treated correspondingly separately for 8 weeks,general condition were observed in all groups, hyper insulin mice uglycemic clamp were used for evaluate IR.All mice werekilled to collect the blood,adipocyte and the muscle.Adiponectin,TNF-α,leptin, PKB/Akt was detected by RT-PCR.
Results
1.Rats model induced by high fat had elevatory body weight,blood sugar and fasting insulin,and had a characteristics of lipid metabolism disorder,the descending of glucose metabolic rate.So this model is comparatively ideal IR animal model.
2.TZP and rosiglitazone could increased glucose infusion rate(M)(P＜0.05、P＜0.01),and could decreased fasting blood glucose and serum insulin、TC、LDL-C (P＜0.05),decreased the body weight of IR model rats.
3.Rats model induced by high fat had elevatory adiponcetin mRNA levels in the epididymis(P＜0.05、P＜0.01),which ramarkable reduce than normal groups. TZP and rosiglitazone could increased adiponcetin mRNA levels in the epididymis (P＜0.05、P＜0.01).
4.Rats model induced by high fat had descending TNF mRNA levels in the epididymis(P＜0.05、P＜0.01),which ramarkable reduce than normal groups.TZP and rosiglitazone could decreased TNF mRNA levels in the epididymis(P＜0.05、P＜0.01).
5.Rats model induced by high fat had elevatory PKB mRNA levels in the epididymis and skeletal muscle(P＜0.05、P＜0.01),which ramarkable reduce than normal groups.TZP and rosiglitazone could increased leptin mRNA levels in the epididymis and skeletal muscle(P＜0.05、P＜0.01).
conclusion
TZP could descended glucose infusion rate(M),improving IR;descended the body weight and improved lipid metabolism disorder of IR model rats;increased adiponcetin mRNA levels in the epididymis;decreased TNF mRNA and levels in the epididymis;increased leptin mRNA levels in the epididymis and skeletal muscle. So TZP have a role of improving IR through effecting the expression of adiponcetin、TNF、liptin and PKB.
引文
[1]第五永长,许建秦.脾不散精中医内涵的再思考[J].陕西中医,2006,27(3):1390
[2]杨文军,庄严.胰岛素抵抗综合征辨治初探[J].山东中医药大学学报,2002,26(4):275-276
[3]姜华.脾阴虚与2型糖尿病相关性的临证探讨[J].天津中医药2008,25(2):132-133
[4]王利明.从痰湿论治胰岛素抵抗[J].现代中西医结志,2003.12(7):783
[5]王晖,王健康.糖尿病辨证论治新识[J].中医杂志,1999,40(8):507-508
[6]刘军,陈影,刘芳,等.肝脏脂肪浸润程度与胰岛素抵抗的相关性研究[J].临床内科杂志,2004,21(2):120-122
[7]王智明.胰岛素抵抗从肝论治的探讨[J].光明中医,2003,(18)6:13-14
[8]张德贵,贺建丽.调肝滋肾法治疗胰岛素抵抗及其相关性疾病之临证与探讨[J].光明中医,2002,17(4):26-27
[9]于淼,朴春丽,南征.2型糖尿病胰岛素抵抗从毒损肝络论治的理论初探[J].上海中医药杂志2007年第41卷第3期
[10]吴深涛.对胰岛素抵抗宜用益肾化瘀、疏利少阳法[J].中医杂志,2001,42(6):332-333
[11]方永奇,曹建宏,方春亮.从温胆汤的方证看痰证实质[J].中国中医基础医学杂志,1998,4(1):49
[12]孙刚,李晓玲.痰浊证型患者糖、脂等指标检测及其临床意义[J].贵阳中医学院学报,1997,19(3):59
[13]范梦男.痰湿体质与2型糖尿病胰岛素抵抗的相关性第辽宁中医药大学学报[J].2008,10(5):69-70
[14]姜兆顺,张胜兰,寇天芹,等.2型糖尿病血瘀证患者血小板CD6-p、CD63测定意义探讨[J].中国中西医结合杂志,1999,19(9):527
[15]施赛珠,陈剑秋,张茂华,等.宏观与微观相结合研究糖尿病血瘀证[J].中医杂志,1997,38(4):233
[16]洗慧.糖尿病从瘀治初探[J].中国医药学报,2000,15(2):132
[17]黄燕飞.脂毒性与2型糖尿病及其并发症的关系.肾脏病与透析肾移植杂志,2002,11(1):58
[18]周国英,武雪萍,衡先培,等.型糖尿病气阴两虚证与胰岛素抵抗的相关性研究[J].福建中医药,2000,31(2):8
[19]王喜瑛,郑姜卿,吕绍光.36例2型糖尿病中医不同证型的胰岛素抵抗观察[J].福建中医学院学报,2003,13(6):9
[20]齐迅,沈欣,陈马力,等.降糖调脂丸对脾虚痰湿型2型糖尿病胰岛素抵抗的影响的实验研究[J].中国中医基础医学杂志,2004,10(4):28-34
[21]刘振杰.扶脾抑胃法治疗胰岛素抵抗性糖尿病[J].湖北中医杂志,2006,28(10):31
[22]徐云生,冯建华.健脾化痰活血法对2型糖尿病胰岛素敏感性的影响[J].山东中医杂志,2004,23(7):394
[23]阮永队,陈红梅,莫冰泉,等.中医温阳健脾法与降糖药合用治疗2型糖尿病胰岛素抵抗阳虚患者70例[J].广州中医药大学学报,2007,24(3):184
[24]陆付耳,杨明炜,邹欣.补肾通脉方对2型糖尿病大鼠胰岛素抵抗的影响.华中科技大学学报(医学版),2002,31(1):73-75
[25]黄冬梅,陆付耳,黄光英.补肾通脉方对胰岛素抵抗大鼠胰岛素信号转导的影响[J].中国中西医结合杂志,2003,23(9):684-687
[26]常宗范,冯奕超.胰岛素抵抗的中医辩证论治[J].吉林中医药,2001,(3):54-55
[27]徐丽君,曾凡鹏,陆付耳,等.补肾通脉方对2型糖尿病大鼠骨骼肌胰岛素受体表达的影响[J].中国医院药学杂志,2003,23(4):201-203
[28]高允珊.滋肾降糖丸对糖尿病大血管病变患者血清脂联素和血管内皮功能的影响[J].2008,5(2):18-20
[29]王智明,魏子孝.从肝论治消渴(糖尿病)理论探讨[J].中国中医基础医学杂志,1999,5(4):34
[30]王智明,龚明伟,李葆华,等.调肝泻火法对2型糖尿病患者炎性标志物水平及胰岛素抵抗的影响[J].中医药学刊,2006,24(3):426
[31]仝小林,柳红芳,朴信映,等.开郁清胃颗粒治疗2型糖尿病胰岛素抵抗的临床研究[J].实用中医内科杂志,2001,15(2):10-11
[32]薛青,王小娟,王亚南,等.清肝泻心滋阴润燥法对2型糖尿病患者脂肪细胞抵抗素及脂联素的影响[J].中医杂志,2007,48(5):411
[33]戴小良,王行宽.清肝泻心滋阴润燥法改善2型糖尿病胰岛素抵抗的研究[J].中医药学刊,2004,22(9):1633
[34]梁兴伦,韩明向.胰岛素抵抗模型大鼠的中医证候研究.中国中西医结合杂志,2001,21(7):528-530
[35]武明东,高天舒,郑曙琴,等.化痰解瘀汤联合胰岛素治疗2型糖尿病疗效观察[J].中医药学刊,2005,23(4):729-730
[36]陈维铭,王馨然.半夏白术天麻汤对单纯性肥胖患者胰岛素抵抗的影响[J].现代中西医结合杂志,2004,13(2):351
[37]赵天豫,郭改会.化瘀解毒法防治胰岛素抵抗2型糖尿病的研究[J].中国中西医结合急救杂志,2002,9(3):176
[38]肖燕倩.糖络饮治疗气阴两虚脉络瘀阻型糖尿病46例[J].辽宁中医学院学报,2004,6(1):35-36
[39]郭乃刚,施毕曼,成兴波,等.2型糖尿病辨证分型与胰岛素抵及胰岛B细胞功能关系 探讨[J]实用中医内科杂志,2002,18(5):405
[40]高志扬,钱少平,易向明,等.2型糖尿病中医分型与B细胞功能、胰岛素敏感性的关系[J].中西医结合心脑血管病杂志,2003,1(1):85
[41]徐成兴,叶伟成,胡蕴刚.120例2型糖尿病患者的中医辨证分型及相关分析[J].上海中医药杂志,2007,41(6):34
[42]汪何.益气养阴活血化淤中药对治疗2型糖尿病胰岛素抵抗的研究[J].中医药学刊,2004,22(7):1282
[43]武士芬.益气养阴活血清热法改善2型糖尿病胰岛素抵抗的临床观察[J].辽宁中医杂志,2003,31(9):720
[44]季聚良,陆源源,车志英.益气养阴活血化痰法对2型糖尿病胰岛素抵抗的临床研究[J].山东中医杂志,2007,26(1):19
[45]杨晓燕,王开成.益气养阴活血方对胰岛素抵抗大鼠血清纤溶酶原激活物抑物的影响[J].中国实验方剂学杂志,2008,14(5):52-54
[46]杨文军,郭宝荣,赵泉霖.中药配合口服降糖药对2型糖尿病患者胰岛素抵抗及微量白蛋白尿的影响[J].山东中医药大学学报,2003,27(4):285-286
[47]卢晓琳.益气养阴活血通腑法治疗胰岛素抵抗综合征52例[J].河北中医,2003,25(4):270-271
[48]何广卫、瞿伟菁。益气养阴清热液对高血糖肥胖大鼠胰岛素抵抗的影响[J].中国药理学通报 2008;24(6):718-722
[49]Brusq JM,AncellinN,GrondinP,etal.Inhibition of lipidsynthe 2 sisthrough activation of AMP kinase:An additional mechanism for the hypolipidemic effects of berberine[J].JLipidRes,2006,47:1281-1288
[50]Lee YS,Kim WS,Kim KH,et al.Berberine,a natural plant product,activates AMP-activated protein kinase with beneficial metabolic effects indiabetic and insulin resistant states[J].Diabetes,2006,55:2256-2264
[51]黄立武,钱海凌,孙淑荣,等.黄芪注射液对老年脑梗死恢复期胰岛素抵抗的影响[J].中国康复理论与实践,2004,10(1):55-56
[52]黄琦,许家鸾.麦冬多糖对2型糖尿病血糖及胰岛素抵抗的影响[J].浙江中西医结合杂志,2002,12(2):81-82
[53]番石榴,于志清.纯单黄酮甙碘胰岛素与脂肪细胞结合的影响[J].广西医学院学报,1980(1):22
[54]朱章志,熊曼琪,林安钟,等.益气养阴活血通腑法对继发性磺脲类失效Ⅱ型糖尿病患者外周胰岛素抵抗的影响[J].中国中医药信息杂志,2002,9(1):25-27
[55]冯世良,高斌,白淑英,等.应用胰岛素敏感性指数研究中药对Ⅱ型糖尿病病人胰岛素抵抗的作用[J].中医杂志,1997,38(2):100
[56]钱秋海,庄乾竹.愈胰饮治疗胰岛素抵抗综合征的临床研究[J].中国中医药信息杂志,2002,9(7):12-14
[57]郭志华,袁肇凯,王东生.四泰片治疗高血压病胰岛素抵抗的临床研究.中成药,2004,26(2):162-164
[58]李学军,杨叔禹.平糖浓缩胶囊对2型糖尿病患者外周血胰岛素抵抗的影响[J].中国中西医结合杂志,2002,22(11):854-855
[59]刘承琴,赵建群,王荣欣,等.健脾化瘀片治疗2型糖尿病胰岛素抵抗患者65例临床研究[J].中医杂志,2006,22(2):22
[60]杨月花.益气养阴活血汤对改善胰岛素抵抗的疗效观察[J].湖北中医杂志,2005,27(2):45-46
[61]陈立群.丹栀逍遥散加味对肥胖伴非酒精性脂肪性肝病及胰岛素抵抗的影响[J].中西医结合肝病杂志,2008,18(1):21-22
[62]王景学,宋建新.生脉散治疗胰岛素抵抗的临床观察[J].光明中医,2007,22(1):60-61
[63]高彦彬,周晖,关菘,等.中药糖脂平胶囊干预糖耐量低减的临床研究[J].北京中医药大学学报,2007,30(12):846-849
[64]杨占华,隋道敬.活胰汤对2型糖尿病胰岛素抵抗的影响[J].中国全科医学,2006,40(3):23
[65]任平安.麻子仁丸加味治疗2型糖尿病临床疗效观察[J].现代中医药,2003,23(1):29-30
[66]钱秋海,王树海,庄乾竹,等.玉泉丸合黄连素治疗2型糖尿病胰岛素抵抗患者30例临床研究[J].中医杂志,2003,44(1):32-33
[67]张玉辉 抵当汤对37例2型糖尿病患者胰岛素抵抗的影响[J].中国中西医结合杂志,2008,28(2):161-162
[68]范朝华 杨宏杰.芪灵汤改善2型糖尿病胰岛素抵抗的临床观察[J].浙江中医杂志,2008,43(2):63-66
[69]周丽斌,陈明道,王晓,等.小檗碱对脂肪细胞分化的影响[J].中华医学杂志,2003,83(4):338
[70]陆灏,叶伟成,丁学屏.黄连素对实验大鼠胰岛素抵抗的影响[J].辽宁中医学院学报,2002,4(4):259-260
[71]周群.植物类降血糖药物的实验研究进展[J].国外医学·药物分册,1987,14(1):27
[72]王银萍,吴家祥,王心蕊,等.人参茎叶皂甙和大豆皂甙对糖尿病大鼠血小板聚集率和TXA2/PGI2系统的影响[J].白求恩医科大学学报,1994,20(2):118
[73]李莹莹,于世家.大黄醇提物对糖尿病肥胖大鼠IR及FFA等影响的研究[J].实用糖尿病杂志,2005,4(1):40-41
[74]万生芳,闻润花.掌叶大黄提取物对实验性2型糖尿病大鼠胰岛素抵抗的实验研究[J].现代中西医结合杂志,2007,16(12):1606
[75]鲁瑾,邹大进,张家庆.黄芪预防肿瘤坏死因子TNF-α所致胰岛素抵抗[J].中国中西医结合杂志,1999,19(7):420-422
[76]毛先晴,欧阳静萍.黄芪多糖对糖尿病KKAy小鼠肝脏脂肪变性的影响[J].中国糖尿病杂志,2008,16(4):233-236
[77]衡先培,张朝春.实用糖尿病手册[M].成都:四川科学技术出版社,2000:144-145
[78]王佳珍,黄小明,陈秀芳.月见草油和多烯康对糖尿病大鼠胰岛素抵抗的治疗作用[J].浙江医学,1998,20(1):24
[79]徐梓辉,周世文,黄林清,等.薏苡仁多糖对实验性2型糖尿病大鼠胰岛素抵抗的 影响[J].中国糖尿病杂志,2002,10(1):44-48
[80]郭洁文,潘竞锵,邱光清,等.荔枝核增强2型糖尿病胰岛素抵抗大鼠胰岛素敏感性作用[J].中国新药杂志,2003,12(7):526-529
[81]徐卫东,林君如,朱姗颖,等.复方苦瓜饮对2型糖尿病大鼠模型胰岛素抵抗的影响[J].江苏大学学报(医学版),2003,13(2):99-100
[82]Vikrant V,Grover JK,Tandon N.Treatment with extracts of momordica charantia and Eugenia jambolana prevents hyper-glycemia and hyperinsulinemia infruct of selfed rats[J].Ethno pharmacol,2001,76(2):139-143
[83]吴正治,李桂云.2型糖尿病胰岛素抵抗中医药研究述评[J].深圳中西医结合杂志,2008,18(1):58-61
[84]黄金海.脑血康对2型糖尿病胰岛素抵抗及超敏C反应蛋白的影响[J].现代中西医结合杂志,2005,14(14):1836-1837
[85]吴迪炯,周鸿,等.杜仲对小鼠胰岛素抵抗干预作用的研究[J].医学研究杂志,2008,37(3):110-112
[86]赵振爱.中药与糖尿病胰岛素抵抗[J].中国误诊学杂志,2007,7(15):3528-3529
[87]曹莉,茅彩萍,顾振纶,等.葛根素对胰岛素抵抗大鼠糖耐量及胰腺组织形态学的影响[J].中国血液流变学杂志,2008,18(1):47-48
[88]宗灿华,田丽梅,等.枸杞多糖对2型糖尿病大鼠胰岛素抵抗及脂联素基因表达的影响[J].中国康复理论与实践,2008,14(6):531-532
[89]王敬,宋光耀,等.银杏叶提取物对高脂胰岛素抵抗大鼠血清瘦素及脂联素的影响[J].北京中医药大学学报.2008,31(1):50-53
[90]刘颖,陆付耳,黄光英,等.丹参对2细胞胰岛素抵抗状态的影响[J].医药导报,2008,27(3):265-267
[91]洪浩,王钦茂,赵帜平,等.丹皮多糖-2对2型糖尿病大鼠的抗糖尿病作用[J].药学通报,2003,38(4):255
[92]沈岚,陆付耳,等.马齿苋对Ⅱ型糖尿病大鼠胰岛素抵抗的影响[J].中国医院药学杂志,2005,25(4):293-295
[93]郑琳颖,潘竞锵,吕俊华,等.白芍总苷增强高脂血症胰岛素抵抗大鼠胰岛素敏感性和降血脂作用研究[J].时珍国医国,2008,19(2):349-351
[94]熊曼琪,林安钟,朱章志,等.加味桃核承气汤对Ⅱ型糖尿病大鼠胰岛素抵抗的影响[J].中国中西医结合杂志,1997,17(3):165-168
[95]陈频,徐向进.复方丹参滴丸对胰岛素抵抗大鼠的保护作用及其机制研究[J].中西医结合心脑血管病杂志,2008,6(5):554-557
[96]周艳.葛根芩连汤对2型糖尿病大鼠的降血糖抗氧化作用[J].中国新医药杂志,2003,2(6):16
[97]付雪艳,董琳.玉液汤对胰岛素抵抗大鼠骨骼肌葡萄糖转运子-4表达的影响[J].时珍国医国药,2008,19(4):921-922
[98]冯锋1,董琳2,张义伟2,于福生3,付雪艳2.玉液汤治疗大鼠胰岛素抵抗实验研究[J].时针国医国药,2008,19(4):945-946
[99]金智生,潘宇清.金匮肾气丸对实验性2型糖尿病胰岛素抵抗大鼠血清TNF-a、Leptin的影响[J].现代中医药,2008,28(3):66-68
[100]钱毅,薛耀明.六味地黄丸对OLETF鼠胰岛素抵抗的影响[J].广东医学,2008,29(3):371-373
[101]程海波,尚文斌,司晓晨.胰敏胶囊阻止高脂膳食诱导大鼠胰岛素抵抗的发生[J].南京中医药大学学报,2003,19(5):281-284
[102]李怡,张前进,李秋贵,等.糖肾胶囊对FFR胰岛素抵抗性与leptin浓度的影响[J].中国实验方剂学杂志,2000,6(1):25-27
[103]李瑾,任志芳.糖康宁对2型糖尿病大鼠胰岛素抵抗的影响[J].江西中医学院学报,2005,17(3):62-63
[104]章小平,方朝晖.参丹健胰丸改善2型糖尿病胰岛素抵抗的机理研究[J].中医药临床杂志,2004,16(6):543-545
[105]申竹芳.金芪降糖片抗糖尿病的药理作用基础[J].国外医学·内分泌分册,2005,24(3):215-216
[106]钱秋海,李玉忠,黄东辉,等.三黄消渴胶囊对Ⅱ型糖尿病模型大鼠胰岛素抵抗的影响[J].山东中医药大学学报,2005,29(5):21-23
[107]王开成,方朝晖.丹蛭降糖胶囊对胰岛素抵抗大鼠脂联素的影响[J].江西中医学院学报,2006,180(2):61
[108]李勇.生芪颗粒对胰岛素抵抗糖尿病大鼠AT1、Ang Ⅱ、ET-1的影响[J].河南中医,2008,28(1):27-30
[109]李勇,刘孟宇,王彦刚.生芪降糖颗粒对胰岛素抵抗鼠的作用及机制研究[J].中国中西医结合杂志,2007,27(5):449
[110]王凌,刘震,李秋贵,等.参地降糖颗粒对胰岛素抵抗的实验研究[J].世界中西医结合杂志,2007,2(4):207.
[111]郭秋慧,李婧,杨静,等.参芪复方合剂对胰岛素抵抗大鼠的治疗作用及机制[J].中国现代医学杂志,2007,17(4):406-409
[112]王东,李敬林,姜良铎,等.糖克煎剂对2型糖尿病模型大鼠胰岛素抵抗的影响[J].中华中医药学刊,2008,26(6):1243-1245
[113]王芬,何华亮.糖耐康对自发性2型糖尿病KKAy小鼠胰岛素信号转导的影响[J].中国实验方剂学杂志,2008,14(1):46-49
[114]苗宇船,张志岗.降脂平肝汤对脂肪肝大鼠胰岛素抵抗的影响[J].山西中医,2008,24(3):45-47
[115]闫爱国,葛争艳.降糖消脂胶囊对2型糖尿病大鼠模型的胰肝脏形态学改变的影响[J].中国中药杂志,2008,33(9):1067-1071
[1]Himsworth.Diabetes mellitus:Its differentiation intoInsulin sen sitive and insulin insensitive type[J].The Lancet,1936,18:127-130
[2]Yalow RS,Berson SA.Immunoassay of endogenous plasma insulin in man[J].Clint Invest,1960,39:l157-1175
[3]De Frantz RA,Tobin JD,Andres R.Glucose clamp technique:a method forquan tifying insulin secretion and resistance[J].Physiol,1979,237(3):214-223
[4]Gerich J,Rizza R,Mandarino L.Assessment of insulin action in humans with Observation on the insulin resistance in non insulin,dependent diabe tes melli tus.In Insulin uptake,[J].Skyler New York,1982,Excerptmedica,74
[5]Reaven GM.Role of insulin in human disease[J].Diabetes,1988,37(12):1595-1607
[6]MP Stern.Diabetes and Cardiovascular disease:The "Common soil" hypothesis [J].Diabetes,1995,44(4):369-374
[7]李秀均.代谢综合征[M].第2版.北京:人民卫生出版社,2007,3:5-7
[8]prokopenko I,McCarthy MI,lindgren CM.TYPE 2 diabetes:new genes,newunder standing[J].Trends Genet,2008,24:613-621
[9]Integrated Management of Cardiovascular RiskReport of a WHO Meeting,2002
[10]Haffner S,Gonzaler C,Miettinen A,et al.A prospective analysis of the Homa model,the Mexico City Diabetes Study.Diabetes Care,1996,19:1138-1141
[11]Jia WP,Xiang WS,Chen L,et al.Epidemiologic study on metabolic symdrome in normal and overweight Chinese in Shanghai[J].Diabetes,1988,37:667-687
[12]Group LC.Insulin resistance:the fundamental trigger of type2 diabe tes.Diabetes Obese metal,1999,1(Supply 1)S:1-7
[13]GM.Role of insulin resistance in human disease[J].Diabetes,1988,15(7):539
[14]Doege H,Boclanski A,Joost HG,et al.The Glut-like family:Anew family of sugar transporters with significant similarity to the glucosetransporters Glut-5[J].Diabetes,2000,49(suppl 1):A30
[15]Mueckler MM,Glucose transporters:Helping sugar slip through the grease [J].Diabetes,1998,47(suppl 1):7
[16]邓尚平.胰岛素免疫原性的临床研究:胰岛素纯度与抗体生成,用药剂量和血糖控制的关系[J].中华内分泌代谢杂志,1987,3:80-82
[17]傅冷西,张小凯,陈红.胰岛素自身抗体与胰岛素抵抗的关系[J].福建医科大学学报,2002,36(1):73-74
[18]姜波,周永列.非胰岛素依赖糖尿病自身抗体和胰岛细胞功能的关系.江西医学检验,2002,20(3):131-133
[19]Chen S,Wiesenthal SR,Lam L,et al.Oleate-induced decrease in hepatocyte insulin binding is mediated by protein kinase C(PKC) activation[J].Diabetes,1999,48(suppl 1):A225
[20]Andrews RC,Walker BR.Glucocorticoids and insulin resistance:old hormones,new targets[J].Clin Sci,1999,96:513-523
[21]张卫卫等.肝硬化胰岛素抵抗及血清生长激素水平的研究[J].世界华人消化杂志,2002,10(10):1180-1183.
[22]Lindsay RS,Lindsay RM,Waddell BJ,et al.Prenatal glucocorticoid exposure leads to offspring hyperglycemia in the rat:studies with the 11βhydroxysteroid dehyrogenase inhibitor carbenoxolone[J].DibeTologia,1996,39:1299-1305
[23]Fishier M,Klein J,Lesser U,et al.Interleukin(IL)6 mRNA Expressionis Stimulated by Insulin,Isoproterenol,Tumor Necrosis Factor Alpha,Growth Hor mone and IL-6 in 3T3-L1 Adiposities[J].Harm Metal Rees,2003,35(3):147-52
[24]罗敏.分子内分泌学(基础与临床)[M].第 版.北京:人民军医出版社.2003;139-140.
[25]Myers,MG,White,MF.The new elements of insulin signaling Insulin receptor substrate -land proteins with SH2 domains[J].Diabetes,1993,42(5):643-650
[26]徐丽君,曾凡鹏,陆付耳,等.补肾通脉方对2型糖尿病大鼠骨骼肌胰岛素受体表达的影响[J].中国医院药学杂志,2003,23(4):201-203
[27]于健,林枫,苏珂,等.2型糖尿病患者正常糖耐量一级亲属红细胞膜胰岛素受体变化及与胰岛素抵抗的相关性[J].中国慢性病预防与控制,2007,15(1):32-33
[28]Shimoyama R,Shelmet JJ,Savage CR,et al.Effects of anti insulin receptoran tibodies(AIRA) on downregulation and turnover ofinsulin rece ptors on cultured Hepatocytes[J].Diabetes,1986,35:2
[29]Mustafa Shin,Elian Kim ET Tetanus,and Nil gun Demurrage Governor,etal.Autoimmune Hypoglycemia in a Type 2 Diabetic Patient with AntiInsulin and Insulin Receptor Antibodies:Response to al[J].Diabetes Care,2004,27(5):1246-1247
[30]Mueckler MM,Glucose transporters:Helping sugar slip through the grease[J].Diabetes,1998,47(suppl 1):7
[31]Taniguchi CM,Emanuelli B,Kahn CR,et al.Critical nodes insig nalling pathways:Insights into insulin action[J].Nat RevMol Cell Bioi,2006,(7):85-96
[32]Luther V,Wojciech W,Lodger K H,et al.Human insulin receptor substrate-2Gene organization and promoter characterization[J].Diabetes,1999,48:1877-1880
[33]Tanti JF,Gremeaus T,Obberghen EV,et al.Insulin receptor substrate 1 isphosphorylated by the serine kinase activity of phosphate dylinositol 3- kinase[J].Biochem J,1994,304:17-21
[34]Lee YH,White MF,et al.Insulin receptor substrate proteins and diabetes[J].Arch Pharm Res,2004,27(3):61-70
[35]White MF.The insulin signaling system andthe IRS proteins[J].Dig betologia,1997,(40):2-17
[36]Bjornholm M,Zierath JR,et al.Insulin signal transduction in hu man skeletal muscle:Identifying the defects in Type Ⅱ diabetes[J].Biochem Soc Trans,2005,33(3):54-57
[37]Amsterdam LL,Gentry W,Jobanputrs S,et al.Anastrazole and oral contrace ptives;A novel treatment for endometriosis[J].Fertil Steril,2004,84(2):300-304
[38]Fatemi HK,Alturki HA,Papanikolaou EG,et al.Successful treatment of an Aggressive recurrent postmenopausal endometriosis with an aroma tize inhibitor.Report Boomed Online.2005,11(4):455-457
[39]Shipper ER,West WJ JR.Successful treatment of severe endometriosis in twoPremenopausal women with an aromas inhibitor.Fertile Steril,2004,81:1395-1398
[40]jianping ye.代谢综合征研究的新进展[J].中国糖尿病杂志,2009,17(2):81-84
[41]Cohen P,Alessi DR,Cross DA.PDK1,one of the missing links ininsulin signal transduction[J].Febs Lett,1997,10(4):3-10
[42]Vanbaesebroeck B,Alessi DR.The PI-3K- PDK connection:more than just a road To PKB[J].Brioche J,2000,346:541-546
[43]Stephens L,Anderson K,Stokoe D,et al.Protein kinase B kinases that mediate phosphatidylinositol 3,4,5trisphos-phate de pendentacti ration of protein kinase B[J].Science,1998,(279):710-714
[44]Duan C,Bauchat JR,Hsieh T.Phosphatidylinositol 3-kinase is required for insulin like growth factor Ⅰ induced vascular smoothmuscle cell pro liferation and migration[J].Circ Res,2000,(86):15-23
[45]魏动,崔巍,王惠芳,等.PI3K/Akt/PKB信号通路与胰岛β细胞功能[J].国际内分泌代谢杂志,2007,27(2):109
[46]Franke TF,Kaplan DR,Cantley LC.P13K:downstream AKTion blocks apo ptosis [J].Cell,1997,88(4):435-437
[47]RajalaMS,Rajala RV,Astley RA,et al.Corneal Cell Survival in Adenovirus Type 19 Infection RequiresPhos phoinositide 32Kinase /Akt /Activationl[J].Virol,2005,79(19):12332-123411
[48]Varma S,Lal BK,Zheng R,et al.Hyperglycemia alters PI3K and Akt signaling and leads to endothelial cell proliferative dysfunction[J].Phy siol Heart Circ Physiol,2005,289(4):H1744-H1751
[49]Ho FM,hin WW,Chen BC,et al.High glucose-inducedapop tosis in human vascular endothelial cells is mediatedthrough NF-kappaB and c-Jun NH2-terminal kinase pathway and p reventedby PI3K/Akt/eNOS pathway[J].Cell Signal,2006,18(3):391-399
[50]James DE.MUNC-ing around with insulin action[J].Clin Invest,2005.115:219-221
[51]张增伟.葡萄糖转运蛋白4在细胞中的生理作用研究进展[J].实用诊断与治疗杂志,2005,19(3):191-193
[52]Began J S,Hendon N,McKee A E,et al.Functional cloning ofTUG as a regulator of GLUT4 glucose transporter trafficking[J].Nature,2003,425(6959):727
[53]Bonnadona RC,Prato SD,Bonora E,et al.Roles of glucose transport and glucose phosphorylation in muscle insulin resistance of NIDDM[J].Diabetes,1996,45:915
[54]Shaw S,Wang X,Red H,et al.High glucose augments the angiogenesisⅡ-induced activation of JAK2 in vascular smooth muscle cells via the polio pathway[J].Boil Chem,2003,278:30634-30641
[55]李震花,张涛,葛志明.高血糖加速动脉粥样硬化的分子生物学机制[J].中国动脉硬化杂志,2006,14(7):633-635
[56]Brownlee MA.The pathbiology of diabetic complications:a unifing me chanism [J].Diabetes.2004,53(Suppl 2):6
[57]Kadowki T.Insights into insulin resistance and type 2 diabetes from knockout mouse models[J].Clin Invest,2000,106(4):459-465
[58]Borden G.Pathogenesis of type 2 diabetes.Insulin resistance[J].Endocrinol Metab ClAn North Am,2001,30(4):801-815
[59]Kelley DE,Williams KV,Price JC,et al.Plasma fatty acids,adiposity,and variance of skeletal muscle insulin resistance in type 2 diabetes mellitus[J].Clint Endocrinal Metab,2001,86(11):5412-5419
[60]Flier is.Clitical conversations:Fat drain,and the regulation of energy balance[J].Diabetes,2005,54(suppl 1):6
[61]Kazuhito Fukui,1 Tsutomu Wada,1 Syota Kagawa,et al.Impact of the Liver-Specific Expression of SHIP2(SH2-Containing Instill 5-Phospha tase 2 onInsulin Signaling and Glucose Metabolism in Mice[J].Diabetes,2005,54(7):1958-1968
[62]Robert K.Hall,Xiao L.Wang,Lena George,et al.Insulin Represses Phos phenol pyruvate Carboxykinase Gene Transcription by Causing the Ra piddisrupt tion of an Active Transcription Complex:A Potentialepigene tic Effect[J].Endocrinol,2007,21(2):550-563
[63]Zong-Chao Ling,Cao Hong-Lie,Claes-G(o|¨)ran(O|¨)stenson,et al.Hypergl ycemia Contributes to Impaired Insulin Response in GK Rat Islets[J].Diabetes,2006, 55(3):590-599
[64]Panarotto D,Remillard P,Bouffard L,et.al.Insulin resistance affects the Regulation of lipoprotein lipase in the postprandial period and in an adipose Tissue-specific manner[J].Ears Clint Invest,2002,32(2):84-92
[65]王涤非,蔡冬梅,蒋丽娟,等.老年胰岛素抵抗小鼠骨骼肌细胞磷脂酰肌醇-3激酶的表达[J].中国现代医学杂志,2006,16(10):1498-1500
[66]Blaak EE,Wolffen buttel BH,Saris WH,et al.Weight reduction and the Impaired plasma-derived free fatty acid oxidation in type 2 diabetes[J].Clint Endocrinal Metab,2001,86(4):1638-1646
[67]Men sink M,Blaak Ivan Beck Meet al.Plasma free fatty acid uptake and Oxidation are already diminished in subjects at high risk for developingtype diabetes[J].Diabetes,2001,50(11):2548-2555
[68]邵致格,孙桂菊,胡曼菁.脂肪分布与胰岛素抵抗[J].现代医学,2005,33(1):63-66
[69]徐炯,李晓惠,顾继安.肿瘤坏死因子α与2型糖尿病关系的探讨[J].2001,24(4):227-229
[70]王东,李敬林.肿瘤坏死因子-α与胰岛素抵抗的研究[J].中医药刊,2003,21(4):560-562
[71]Ruan H,Lodish HF Insulin resistance in adipose tissue directand indireete fleets of tumornecrosis factoralpha[J].Cytokine Growth Factor Rev,2003,14(5):447-455
[72]Ken Ishizuka,Isao Usui,Yukiko Kantian,et al.Chronic TNF-α Treat ment Causes Insulin Resistance via IRS-1 Serine Phosphorylation and SOCS3 Induction In 3T3-L1 Adiposities[J].Endocrinology,2007,3(22):doi:10.1210/en.2006-1702
[73]Hube F,Hauner H.The role of TNF-alpha in human adiposetissue:prevention of weight gain at the expense of insulin resistance[J].Horm Metab Res,1999,31:626-631
[74]Hotamisligit GS.Mechanisms of TNF-alpha-induced insulin resi stance[J].Exp Clin Endocrinol,1999,107:119-125
[75]周红文.脂肪组织的内分泌功能[J].国外医学内分泌学分册,2002,22(1):34-36
[76]RotterV NagaevI,Smith U.Interleukin-6 induces insulin resistance in 3T3-L1 adipocytea and is like IL-8 and TNF-alpha ovel rexpressed in human fat cells from insulin sistant subjects[J].Biol Chem,2003,278(46):45777-45784
[77]Peraldi P,Hotamisligil GS,Burman WA,et al.tumor necrosis factor(TNF)-αinhibits insulin signalling through stimulation of the P55TNF receptor and activation of sphingomyelinase[J].Biol Chem,1996,271:13018.
[78]Paola Di Rocco,Melania Manco,Giuseppina Rosa,et al.Lowered Tumor Necrosis Factor Receptors,but Not Increased Insulin Sensitivity,with Infliximab[J]. Obesity Research,2004,12(4):734-738.
[79]Weyer C,Funshashi T,Tanaka S,et al.Hypoadiponectinemia in obesity and type diabetes:close association with insulin resistance and hyperinsulinemia [J].J Clin Endorinal Metab,2001,86(5):1930-1935.
[80]Yamauchi T,Kamon J,Waki H,et al.The fat-derived hormone adiponec tin reverses insulin resistance associated with both lipoatrophy and obesity[J].Nat Med,2001,7(8):941-946
[81]Hu FB,Dofia A,LI T,et al.Genetic variation at the adiponectin locus and risk of type 2 diabetes in women[J].Diabetes,2004,53(1):209-213
[82]Engeli S,Feldpausch M,Gorzelniak K,et al.Association.between adi ponectin and ediators of inflammationinobesewomen[J].Diabetes,2003,52(4):942-947
[83]Fasshauer M,Kralisch S,Klier M,et al.Adiponectin gene expression and secretion is inhibited by interleukin-6 in 3T3-L1 adipocyte[J].Bio Chem.Biophys Res Commun,2003,301(4):1045-1050
[84]李强翔,钟惠菊.脂肪细胞因子与胰岛素抵抗及2型糖尿病[J].国际生物制品学杂志,2007,30(1):27-30
[85]Kirchgessner TG,Uysal KT,Wiesbrock SM,et al.TNF-α contributes to obesity-related hyperleptinemia by regulatoing ieptin release from adipocytes [J].Clin Invest,1997,100(11):2772-2782.
[86]Kristina W,Ville W,David S,et al.Intracerebroventricular inter leukin-6 treatment decreases body fat in rats[J].Biochem Biophys Res Commun,2002,293(1):560-565.
[87]Senn JJ,Klover PJ,Nowak IA,et al.Suppressor of eytokine signaling-3(SOCS-3),a potential mediator of interleukin-6-dependent insulin resistance in hepatocytes[J].BiolChem,2003,278(16):13740-13746
[88]Rotter V,Nagaev I,Smith U.Interleukin-6(IL-6)induces insulin resistance in 3T3-L1 adipocytes and is,like IL-8 and TNFalpha,overexp ressed in human fatcells from insulin resistant subjects[J].Biol Chem,2003,278(46):45777-45784
[89]Muse ED,Obici S,Bhanot S,et al.Roleofresistinindiet2indwedheaptis Insuunre sistance[J].ClinInvest,2004,114:232-239
[90]Rangwala SM,Rich AS,Rhosdes B,et al.Abnovmalglulosehomeostas is duetochroni chyperresistinemia[J].Diaetes,2004,53:1937-1941
[91]SatohH,NguyernMT,MilesPD,etal.Adenovirusmediatedchornic/hyperresistinemi aOleadstoinvivoinsulinresistanceinnormalrats[J].ClinInvest,2004,114:224-231
[92]FukuharaA,MatsudaM,NishizawaM,etallVisfatin:aproteinsecretedby Vis ceral fatthatmimicstheeffectsofinsulinl[J].Science,2005,307:426-430
[93]Bottcher Y,Teupser.D,Enigk B,et al.Genetic variationinthevis fatgene (PBEF1)and itsrelationto glucose metabo lismandfat depospecificmessen gerri bonucleicaci dexpressionin humans[J].JClEndocrinolMetab,2006,91(7):2725-2731
[94]Vama V,Yao-BorengasserA,RasouliN,et al.Human visfatin expression rela tionship to insulin sensitivity,in tram yocellu lar and inflammation[J].Clin EndocrinolMetab,2007,92(2):666-672
[95]Michalik L,Wahli W.Peroxisome proliferator-activated receptors:three isotypes for amultitude of functions[J].Curr Opin Biotechnol,1999,10(6):564-570
[96]Willson TM,Brown PJ,Sternbach DD,et al.The PPARs:from orphan recap tors to drugdiscovery[J].J Med Chem,2000,43(4):527-550
[97]Iwata M,Haruta T,Usui I,et al.Pioglitazone ameliorates tumor necro sis factor-alpha-inducedinsulin resistance by a mechanism indepen dent of adipogenic activity of peroxisomeproliferator-activated receptor gamma[J].Diabetes,2001,50(5):1083-1092
[98]RA DeFrantz,JD Tobin and R Andres.Glucose clamp technique:a method forQuantifying insulin secretion and resistance[J].Am J Physiol Endoc rinol Metab,1979,237(9):E214-E223
[99]E.W.Krueger,D.E.James,S.P.Bennett,et al.In vivo insulin sensi tivity In the rat determined by euglycemic clamp[J].Am J Physiol Endocrinol Metab,1983,245(7):E1-E7
[100]GM Reaven,RJ Brand,YD Chen,et al.Insulin resistance and insulin secretion is determinants of oral glucose tolerance in normal individual ls[J].Diabetes,1993,42(9):1324-1332
[101]李芳萍.胰岛素抵抗方法体内检测方法[J].国外医学内科学分册,1998,25(3):108-111
[102]张建,华琦.代谢综合症[M].第版.北京:人民卫生出版社,2003:92-98
[103]Haffner S,Gonzaler C,Miettinen A,et al.A prospective analysis of the Homa model,the Mexico City Diabetes Study[J].Diabetes Care,1996,19:1138-1141
[104]李光伟,潘孝仁,LilliojaS,et al.检测人群胰岛素敏感性的一项新指数[J].中华内科杂志,1993,32:656-660
[105]Banerfi MA,Chaiken RL,Gordon D,et al.Dose intra-abdominal adipose Tissue in black,men determine whether NIDDM is insulin resistance or Insulinsensitive [J].Diabetes,1995,44:141-146
[106]Cede Holm J,Libel L.Insulin release and peripheral sensitivity at theoral glucose tolerance test[J].Diabetes Res Clin Pract,1990,10:167-175
[107]Caro JF,Clinical review 26.Insulin resistance in obese and nonobese Man[J].JClin Endocrinol Metab,1991,73:691-695
[108]Katz A,Nambi SS,Mather K,et al.Quantitative insulin sensitivity check index:a simple,accurate method for assessing insulin sensitivity in humans.J Clin Endocrinol Metab,2000,85;2402-2410
[109]Yokoyama H,Emote M,Fujiwara S,et al.Quantitative insulin sensitivity Check index and the reciprocal index of homeostasis model assessment in normal Range weight and moderately obese type 2diabetic patients[J].Diabetes Care,2003,26:2426-2432
[110]Consoli A,Devangelio E.rhiazolidinediones andinflammation[J].Lupus,2005,14(9):749-797
[111]Kanatani Y,Usui I,Ishizuka K,et al.Effects ofpjioaglitazone on suppressor of cytokine signaling 3expression:potential mechanism for its effects on insulin sensitivity and adiponectin expression[J].Diabetes,2007,56(3):795-803
[112]Ialenti A,Grassia G,DI Meglio P,et al.Mechanism of the antiinflamematory effect of thiazolidinediones:relationship with the glucocoticoidpathway[J].Pharmacol,2005,67(5):1620-1628
[113]黄伟,岑均达.非噻唑烷二酮类胰岛素增敏剂的研究进展.中国医药工业杂志,2002,33(6):299-304
[114]Zhu X,Zhou A,Dey A,et al.Ihsroptionof PC1/3 erpression in mice causes Dwarfism and multiple neuroendocrine peptide processing defects.Proc Natl Acad Sci USA,2002,99:10293-10298
[115]战云飞,郑少雄.胰升糖素样肽-1的研究进展[J].国际内分泌杂志,2006,26(4):62-64
[116]Egan JM,Meneilly GS,Elahi D.Effects of 1 mo bolus subcutaneous admini stration of exendin -4in Type 2 Diabetes.Am J Physiol EndocrinolMetab,2003,284:E1072-1079
[1]宫环,张铁梅,李怡,等.不同饲料配方及喂饲方法制备不同胰岛素敏感性大鼠模型的研究[J].中华糖尿病杂志,2005,13(6):455-452.
[2]RA DeFronzo,JD Tobin and R Andres Glucose clamp technique:a method for Quantifying insulin secretion and resistance.Am J Physiol Endocrinol Metab,1979,237(9);E214-E223.
[3]董晓华,张丹参,武海霞.衰老动物模型的研究进展及评价.河北北方学院学报,2004:21(6):41-43
[4]王双,李峻,李秀钧,等.老龄SD大鼠胰岛细胞形态功能研究[J].四川大学学报(医学版),2008,39(2):197-201
[5]王亚楼,刘星.胰岛素增敏剂的临床应用和开发现状[J].中国药物应用与监测,2005,3:21
[6]Spiegelman BM.PPAR:adipogennic regulator and thiazolidioneRecaptor[J].Diabetes,1998,47(4):507
[7]Yu L Y,Li XR,Fang X.Inhibitory effect of totalflavonoids from mulberry tree leaf on small intestinedisaccharidases in diabetic rat s.Zhonghua Nei Fen MiDai Xie Za Zhi.2002;18(4):313-315.Chinese withabst ract in English
[8]刘颖,陆付耳,黄光英,等.丹参对2细胞胰岛素抵抗状态的影响[J].医药导报,2008,27(3):265-267
[9]周丽斌,陈明道,王晓,等.小檗碱对脂肪细胞分化的影响[J].中华医学杂志,2003,83(4):338
[10]Lee YS,Kim WS,Kim KH,et al.Berberine,a naturalplant product,activates AMPactivated protein kinase with beneficial metabolic effects in diabetic and insulinresistant states.Diabetes.2006;55(8):2256-2265
[11]Yang LJ,Yu H Y,Mu YM,et al.Emodin stimulates glucose uptake by Hep G2hepatocyte through activation of PPARγ[J].Zhong Hua Nei Fen Mi Dai Xie Za Zhi.2007;23(3):264-268.Chinese with abst ract in English
[12]万生芳,闻润花.掌叶大黄提取物对实验性2型糖尿病大鼠胰岛素抵抗的实验研究[J].现代中西医结合杂志,2007,16(12):1606
[13]Monzillo LU,Hamdy O,Evaluation of insulin sensitivity in clinical practice and in research settingsl[J].Nutr Rev,2003,61(12):397-412
[14]Ferranninio E,MariA,How to measure insulin sensitivity[J].JHy Pertens,1998,16(7):895-906
[15]Kraegen EW,James DE,Bennett SP,et al In viw insulin sensi tivity in the rat determ fined by euglycem is clamp[J].Am J Physioj,1983,245(1):E1-E7
[16]李晨钟,张素华,舒昌达,等.大鼠正常血糖-高血浆胰岛素钳夹技术[J].重庆医科大学学报,1998,23(3),149-152
[17]罗谋伦,郭欲晓,林志彬,等.大鼠正糖钳实验方法学[J].药学学报,1999,34(4),255-259
[28]尚敬,孙晖,等.清醒状态下大鼠尾动静脉插管高胰岛素-正糖钳夹实验[J].上海交通大学学报(医学版),2006,25(9):968-971
[19]Storlien LH,Oakes ND,Pan DA,et al Syndromes of insulin resistAnce in the rat Inducementby diet and amelioration withbenfluorex[J].Diabetes,1993,42(3):457-462
[20]戚本玲,成蓓,张丽莉,等.罗格列酮对代谢综合征大鼠瘦素和TNF-α的影响[J].中国医院药学杂志,2008,28(6):446-449
[1]高彦彬,周辉,关崧,等.中药糖脂平胶囊干预糖耐量低减的临床研究[J].北京中医药大学学报,2007,30(12):846-849
[2]潘琳 实验性糖尿病病理图谱[M].科学出版社,2007,9:18
[3]Haffner SM,Kennedy E,Gonzalez C,et al.A prospective analysis oft he HOMA model.The Mexico City Diabetes Study[J].DiabetesCare,1996,19(10):1138-1141
[4]Ileen L Whiteman,Han Cho,MorrisJ,Birnbaum.Roleof Akt/Proteinkinase Bin metabolism.TrendsinEndocrinology andMetabolism,2002,13(12):444-451
[5]SternMP.Natural history ofmacrovascular disease in type 2 diabetes[J].Diabetes Care,1999,22(Suppl3):C2-C5
[6]Yu JG,Javorschi S,Hevener AL,etal.The effecto fthiazolidine dionesonplasmaa diponectinlevelsinnormal,obeseantype2diaeticsubjects[J].Diabetes,2002,51(12):2968-2974
[7]黄志强.内分泌代谢疾病[M].天津:天津科学技术出版社,2002:330-331
[8]李秀钧,赵铁耘.脂肪内分泌激素与糖尿病[J].辽宁实用糖尿病杂志,2002,9(2):49-51
[1]Scherer PE,Willians S,Fogliano M,et al.A novel serumprotein similar to Clq,produced exclusivelyin adipocytes[J].J Biol Chem,1995,270(45):2646-2649
[2]YamauchiT,KamonJ,MinokoshiY,etal.Adiponectinstimulatesglucoseutilizationa ndfatty2acidoxidationbyactivatingAMPactivatedproteinkinase[J].NatMed,2002,8:1288-1295
[3]OkamotoY,AritaY,NishidaM,etal.Anadipocytederivedplasmaprotein,adiponectin ,adherestoinjuredvascularwalls[J].HormMetabRes,2000,32:47-50.
[4]何云,崔克勤.血清脂联素水平与2型糖尿病胰岛素抵抗的关系[J].河北医药,2008,30(3):276-277
[5]AritaY,KiharaS,OuchiN,etal.Paradoxicaldecreaseofanadipocytespecificprotei n,adiponectin,inobesity[J].BiochemBiophysResCommun,1999,257:79-83
[6]WinzellMS,NogueirasR,DieguezC,etal.DualactionoAdiponectinoninSulinsecreti onininsulin-resistantmi[J].BiochemBiophysResCommun,2004,321(1):154-60
[7]YamauchiT,KamonJ,WakiH,etal.Globularadiponectinprotectedobobmicefromdiabe tesandApoE-deficientmicefromatherosclerosis[J].JBiolChem,2003,278(4):2461-8
[8]赵运果,刘宏.脂联素与肥胖、2型糖尿病及心血管疾病的相关性[J].医学临床研究,2008,25(5):941-942
[9]HottaK,FunahashiT,AritaY.Plasmaconcentrationsofnoval,adipose-specificprot ein,adiponectin,intype2diabetipatient[J].ArteriosclerThromb VascBiol,2000,20(6):1595-9.
[10]YokoyamaH,EmotoM,MoriK,etal.Plasma adiponectin leveisassociated with insulin stimulated nonoxidativeglucosedisposa[J].Clint endocrine ol Metab,2006,91(1):290-4
[11]Yamauchi T,Kamon J,Waki H,et al.The fat-derived hormone Adi ponectin reverses insulin resistance associated with both lipoatrophy and obesity[J].Nat Med,2001,7:941-946
[12]McGarry JD.W hat if M inkaa ski had been ageusiC An alter nativeangle on diabetes[J].Science 1992 258(5083):766-770
[1]徐炯,李晓惠,顾继安.肿瘤坏死因子α与2型糖尿病关系的探讨[J].2001,24(4):227-229
[2]王东,李敬林.肿瘤坏死因子-α与胰岛素抵抗的研究[J].中医药学刊,2003,21(4):560-562
[3]Ruan H,Lodish HF Insulin resistance in adipose tissue directand indireet effeets of tumor necrosis factor alpha[J].Cytokine Growth Factor Rev.2003,14(5):447-455
[4]Ken Ishizuka,Isao Usui,Yukiko Kantian,et al.Chronic TNF-α Trea tment Causes Insulin Resistance via IRS-1 Serine Phosphorylation and SOCS3 Induction In 3T3-L1 Adiposities.Endocrinology.2007,3(22);doi:10.1210/en.2006-1702
[5]Hube F,Hauner H.The role of TNF-alpha in human adiposetissue:prevention of weight gain at the expense of insulin resistance[J]Horm Metab Res,1999,31:626-631
[6]周红文.脂肪组织的内分泌功能.国外医学内分泌学分册[J].2002,22(1);34-36
[7]RotterV NagaevI,Sm ith U.Interleukin-6 induces insulin resistance in 3T3-L1 adipocytea and is 1 ike IL-8 and TNF-alpha ovelrexpre ssed in human fat cells from insulin-2sistant subjects[J].JBiol Chem,2003,278(46):45777-45784
[8]Peraldi P,Hotamisligil GS,Burman WA,et al.tumor necrosis factor(TNF)-αinhibits insulinsignalling through stimulation of theP55 TNF receptor and activation ofsphingomyelinase[J].J Biol Chem,1996,271:13018
[9]Paola Di Rocco,Melania Manco,Giuseppina Rosa,et al.Lowered Tumor Necrosis Factor Receptors,but Not Increased Insulin Sensitivity,With Infliximab[J].Obesity Research,2004,12(4):734-738
[10]GuptaA,TenS,AnhaltHl Serum levels of soluble tumorn ecrosis factor Al phareceptor 2 are linked to insulin resistance and glucoseintol erancein chil dren[J].JP ediatr Endocrinol Metab,2005,18(1):75-82
[1]Jones PF,Jakubowicz T,Pitossi FJ et al.Molecular cloning and iden tifica
tion of a serine/threonine protein kinase of the secondmessenger subfamily[J].
Proc N at1Aca Sci,1991,88:4171-5
[2]Staal SP,HartleyJW,RoweWP.Isolation of transformingmurineleukemia viruses
from mice with ahigh incidence of spontaneous lymphoma[J].Proc N at1Aca Sci,
1977,74:3065-7
[3]Nicholson KM,Anderson NG1 The protein kinase B/Aktsignalling pathway in
human malignancy[J].Ce11 Signal,2002,14(5):381-95
[4]Cohen P,Alessi DR,Cross DA.PDK1,one of the missing links ininsulin signal
transduction[J].Febs Lett,1997,(410):3-10
[5]Stephens L,Anderson K,Stokoe D,et al.Protein kinase B kinases that mediate
phosphatidylinositol 3,4,5-trisphosphatedependent activation of protein kinase B[J].Science,1998,(279):710-714
[6]Cross DAE,Alessi DR,Cohen P,et al.Inhibition of glycogenSyn thase kinase-3by insulin mediated by protein kinaseB[J].Nature,1995,(378):785-789
[7]Duan C,Bauchat JR,Hsieh T.Phosphatidylinositol 3-kinase is required for insulinlikegrowth factor-I induced vascularsmooth muscle cell prolix feration and migration[J].Circ Res,2000,(86):15-23
[8]SmithU.Impaired (diabetic.)insulinsigna lingandactionoccurin fat ce llslong beforeglucoseintoleranceis insulinresistance initiatedintheadi posetissue IntJObesRetatMetabDisord.2002,26:897-904
[9]SmithU,AxelsenM,CarvalhoE,etal.InsulinsignalingandacTioninfatcells:associ ation swith insulinresistance and type 2diabetes.AnnNYAcad Sci.1999,892:119-126
[1]马学毅.现代糖尿病诊断治疗学,第一版[M].人民军医出版社,2007,9:169
[2]BeesonM,SajanMP,DizonM,etal.ActivationofproteinkinaseCzetabyinsulinandpho sphatidylinosi2to123,4,52(PO4)3isdefectiveinmuscleintypediabetesandimpairedg lucosetolerance:ameliorationbyrosiglitazoneandexercise[J].Diabetes,2003,52:1926
[3]王君,陈祥贵,李鑫等.人类胰岛素信号通路基因表达分析[J].西华大学学报.自然科 学版,2008,27(1)：36-39
[4]StumvollM,GoldsteinBJ,VanHaeftenTW.Type2diabetes:principlesof pathogene sisandtherapy[J].Lancet,2005,365:1333
[5]KirwanJP,DelAguilaLF.Insulinsignalling,exerciseandcellularintegrity[J].Bi ochemSocTrans,2003,31:1281
[6]MeyerMM,LevinK,GrimmsmannT,etal.Troglitazonetreatmentincreasesproteinkina seBphosphorylationinskeletalmuscleofnormoglycemicsubjectsariskforthedevelopm entoftype2diabetes[J].Diabetes,2002,51:2691
[7]Stephens L,Anderson K,Stokoe D,et al.Protein kinase B kinases that mediate phosphatidylinositol 3,4,5-trisphos-phate-dependent activation of protein kinase B[J].Science,1998,(279):710-714
[2]杨文军,庄严.胰岛素抵抗综合征辨治初探[J].山东中医药大学学报,2002,26(4):275-276
[3]姜华.脾阴虚与2型糖尿病相关性的临证探讨[J].天津中医药2008,25(2):132-133
[4]王利明.从痰湿论治胰岛素抵抗[J].现代中西医结志,2003.12(7):783
[5]王晖,王健康.糖尿病辨证论治新识[J].中医杂志,1999,40(8):507-508
[6]刘军,陈影,刘芳,等.肝脏脂肪浸润程度与胰岛素抵抗的相关性研究[J].临床内科杂志,2004,21(2):120-122
[7]王智明.胰岛素抵抗从肝论治的探讨[J].光明中医,2003,(18)6:13-14
[8]张德贵,贺建丽.调肝滋肾法治疗胰岛素抵抗及其相关性疾病之临证与探讨[J].光明中医,2002,17(4):26-27
[9]于淼,朴春丽,南征.2型糖尿病胰岛素抵抗从毒损肝络论治的理论初探[J].上海中医药杂志2007年第41卷第3期
[10]吴深涛.对胰岛素抵抗宜用益肾化瘀、疏利少阳法[J].中医杂志,2001,42(6):332-333
[11]方永奇,曹建宏,方春亮.从温胆汤的方证看痰证实质[J].中国中医基础医学杂志,1998,4(1):49
[12]孙刚,李晓玲.痰浊证型患者糖、脂等指标检测及其临床意义[J].贵阳中医学院学报,1997,19(3):59
[13]范梦男.痰湿体质与2型糖尿病胰岛素抵抗的相关性第辽宁中医药大学学报[J].2008,10(5):69-70
[14]姜兆顺,张胜兰,寇天芹,等.2型糖尿病血瘀证患者血小板CD6-p、CD63测定意义探讨[J].中国中西医结合杂志,1999,19(9):527
[15]施赛珠,陈剑秋,张茂华,等.宏观与微观相结合研究糖尿病血瘀证[J].中医杂志,1997,38(4):233
[16]洗慧.糖尿病从瘀治初探[J].中国医药学报,2000,15(2):132
[17]黄燕飞.脂毒性与2型糖尿病及其并发症的关系.肾脏病与透析肾移植杂志,2002,11(1):58
[18]周国英,武雪萍,衡先培,等.型糖尿病气阴两虚证与胰岛素抵抗的相关性研究[J].福建中医药,2000,31(2):8
[19]王喜瑛,郑姜卿,吕绍光.36例2型糖尿病中医不同证型的胰岛素抵抗观察[J].福建中医学院学报,2003,13(6):9
[20]齐迅,沈欣,陈马力,等.降糖调脂丸对脾虚痰湿型2型糖尿病胰岛素抵抗的影响的实验研究[J].中国中医基础医学杂志,2004,10(4):28-34
[21]刘振杰.扶脾抑胃法治疗胰岛素抵抗性糖尿病[J].湖北中医杂志,2006,28(10):31
[22]徐云生,冯建华.健脾化痰活血法对2型糖尿病胰岛素敏感性的影响[J].山东中医杂志,2004,23(7):394
[23]阮永队,陈红梅,莫冰泉,等.中医温阳健脾法与降糖药合用治疗2型糖尿病胰岛素抵抗阳虚患者70例[J].广州中医药大学学报,2007,24(3):184
[24]陆付耳,杨明炜,邹欣.补肾通脉方对2型糖尿病大鼠胰岛素抵抗的影响.华中科技大学学报(医学版),2002,31(1):73-75
[25]黄冬梅,陆付耳,黄光英.补肾通脉方对胰岛素抵抗大鼠胰岛素信号转导的影响[J].中国中西医结合杂志,2003,23(9):684-687
[26]常宗范,冯奕超.胰岛素抵抗的中医辩证论治[J].吉林中医药,2001,(3):54-55
[27]徐丽君,曾凡鹏,陆付耳,等.补肾通脉方对2型糖尿病大鼠骨骼肌胰岛素受体表达的影响[J].中国医院药学杂志,2003,23(4):201-203
[28]高允珊.滋肾降糖丸对糖尿病大血管病变患者血清脂联素和血管内皮功能的影响[J].2008,5(2):18-20
[29]王智明,魏子孝.从肝论治消渴(糖尿病)理论探讨[J].中国中医基础医学杂志,1999,5(4):34
[30]王智明,龚明伟,李葆华,等.调肝泻火法对2型糖尿病患者炎性标志物水平及胰岛素抵抗的影响[J].中医药学刊,2006,24(3):426
[31]仝小林,柳红芳,朴信映,等.开郁清胃颗粒治疗2型糖尿病胰岛素抵抗的临床研究[J].实用中医内科杂志,2001,15(2):10-11
[32]薛青,王小娟,王亚南,等.清肝泻心滋阴润燥法对2型糖尿病患者脂肪细胞抵抗素及脂联素的影响[J].中医杂志,2007,48(5):411
[33]戴小良,王行宽.清肝泻心滋阴润燥法改善2型糖尿病胰岛素抵抗的研究[J].中医药学刊,2004,22(9):1633
[34]梁兴伦,韩明向.胰岛素抵抗模型大鼠的中医证候研究.中国中西医结合杂志,2001,21(7):528-530
[35]武明东,高天舒,郑曙琴,等.化痰解瘀汤联合胰岛素治疗2型糖尿病疗效观察[J].中医药学刊,2005,23(4):729-730
[36]陈维铭,王馨然.半夏白术天麻汤对单纯性肥胖患者胰岛素抵抗的影响[J].现代中西医结合杂志,2004,13(2):351
[37]赵天豫,郭改会.化瘀解毒法防治胰岛素抵抗2型糖尿病的研究[J].中国中西医结合急救杂志,2002,9(3):176
[38]肖燕倩.糖络饮治疗气阴两虚脉络瘀阻型糖尿病46例[J].辽宁中医学院学报,2004,6(1):35-36
[39]郭乃刚,施毕曼,成兴波,等.2型糖尿病辨证分型与胰岛素抵及胰岛B细胞功能关系 探讨[J]实用中医内科杂志,2002,18(5):405
[40]高志扬,钱少平,易向明,等.2型糖尿病中医分型与B细胞功能、胰岛素敏感性的关系[J].中西医结合心脑血管病杂志,2003,1(1):85
[41]徐成兴,叶伟成,胡蕴刚.120例2型糖尿病患者的中医辨证分型及相关分析[J].上海中医药杂志,2007,41(6):34
[42]汪何.益气养阴活血化淤中药对治疗2型糖尿病胰岛素抵抗的研究[J].中医药学刊,2004,22(7):1282
[43]武士芬.益气养阴活血清热法改善2型糖尿病胰岛素抵抗的临床观察[J].辽宁中医杂志,2003,31(9):720
[44]季聚良,陆源源,车志英.益气养阴活血化痰法对2型糖尿病胰岛素抵抗的临床研究[J].山东中医杂志,2007,26(1):19
[45]杨晓燕,王开成.益气养阴活血方对胰岛素抵抗大鼠血清纤溶酶原激活物抑物的影响[J].中国实验方剂学杂志,2008,14(5):52-54
[46]杨文军,郭宝荣,赵泉霖.中药配合口服降糖药对2型糖尿病患者胰岛素抵抗及微量白蛋白尿的影响[J].山东中医药大学学报,2003,27(4):285-286
[47]卢晓琳.益气养阴活血通腑法治疗胰岛素抵抗综合征52例[J].河北中医,2003,25(4):270-271
[48]何广卫、瞿伟菁。益气养阴清热液对高血糖肥胖大鼠胰岛素抵抗的影响[J].中国药理学通报 2008;24(6):718-722
[49]Brusq JM,AncellinN,GrondinP,etal.Inhibition of lipidsynthe 2 sisthrough activation of AMP kinase:An additional mechanism for the hypolipidemic effects of berberine[J].JLipidRes,2006,47:1281-1288
[50]Lee YS,Kim WS,Kim KH,et al.Berberine,a natural plant product,activates AMP-activated protein kinase with beneficial metabolic effects indiabetic and insulin resistant states[J].Diabetes,2006,55:2256-2264
[51]黄立武,钱海凌,孙淑荣,等.黄芪注射液对老年脑梗死恢复期胰岛素抵抗的影响[J].中国康复理论与实践,2004,10(1):55-56
[52]黄琦,许家鸾.麦冬多糖对2型糖尿病血糖及胰岛素抵抗的影响[J].浙江中西医结合杂志,2002,12(2):81-82
[53]番石榴,于志清.纯单黄酮甙碘胰岛素与脂肪细胞结合的影响[J].广西医学院学报,1980(1):22
[54]朱章志,熊曼琪,林安钟,等.益气养阴活血通腑法对继发性磺脲类失效Ⅱ型糖尿病患者外周胰岛素抵抗的影响[J].中国中医药信息杂志,2002,9(1):25-27
[55]冯世良,高斌,白淑英,等.应用胰岛素敏感性指数研究中药对Ⅱ型糖尿病病人胰岛素抵抗的作用[J].中医杂志,1997,38(2):100
[56]钱秋海,庄乾竹.愈胰饮治疗胰岛素抵抗综合征的临床研究[J].中国中医药信息杂志,2002,9(7):12-14
[57]郭志华,袁肇凯,王东生.四泰片治疗高血压病胰岛素抵抗的临床研究.中成药,2004,26(2):162-164
[58]李学军,杨叔禹.平糖浓缩胶囊对2型糖尿病患者外周血胰岛素抵抗的影响[J].中国中西医结合杂志,2002,22(11):854-855
[59]刘承琴,赵建群,王荣欣,等.健脾化瘀片治疗2型糖尿病胰岛素抵抗患者65例临床研究[J].中医杂志,2006,22(2):22
[60]杨月花.益气养阴活血汤对改善胰岛素抵抗的疗效观察[J].湖北中医杂志,2005,27(2):45-46
[61]陈立群.丹栀逍遥散加味对肥胖伴非酒精性脂肪性肝病及胰岛素抵抗的影响[J].中西医结合肝病杂志,2008,18(1):21-22
[62]王景学,宋建新.生脉散治疗胰岛素抵抗的临床观察[J].光明中医,2007,22(1):60-61
[63]高彦彬,周晖,关菘,等.中药糖脂平胶囊干预糖耐量低减的临床研究[J].北京中医药大学学报,2007,30(12):846-849
[64]杨占华,隋道敬.活胰汤对2型糖尿病胰岛素抵抗的影响[J].中国全科医学,2006,40(3):23
[65]任平安.麻子仁丸加味治疗2型糖尿病临床疗效观察[J].现代中医药,2003,23(1):29-30
[66]钱秋海,王树海,庄乾竹,等.玉泉丸合黄连素治疗2型糖尿病胰岛素抵抗患者30例临床研究[J].中医杂志,2003,44(1):32-33
[67]张玉辉 抵当汤对37例2型糖尿病患者胰岛素抵抗的影响[J].中国中西医结合杂志,2008,28(2):161-162
[68]范朝华 杨宏杰.芪灵汤改善2型糖尿病胰岛素抵抗的临床观察[J].浙江中医杂志,2008,43(2):63-66
[69]周丽斌,陈明道,王晓,等.小檗碱对脂肪细胞分化的影响[J].中华医学杂志,2003,83(4):338
[70]陆灏,叶伟成,丁学屏.黄连素对实验大鼠胰岛素抵抗的影响[J].辽宁中医学院学报,2002,4(4):259-260
[71]周群.植物类降血糖药物的实验研究进展[J].国外医学·药物分册,1987,14(1):27
[72]王银萍,吴家祥,王心蕊,等.人参茎叶皂甙和大豆皂甙对糖尿病大鼠血小板聚集率和TXA2/PGI2系统的影响[J].白求恩医科大学学报,1994,20(2):118
[73]李莹莹,于世家.大黄醇提物对糖尿病肥胖大鼠IR及FFA等影响的研究[J].实用糖尿病杂志,2005,4(1):40-41
[74]万生芳,闻润花.掌叶大黄提取物对实验性2型糖尿病大鼠胰岛素抵抗的实验研究[J].现代中西医结合杂志,2007,16(12):1606
[75]鲁瑾,邹大进,张家庆.黄芪预防肿瘤坏死因子TNF-α所致胰岛素抵抗[J].中国中西医结合杂志,1999,19(7):420-422
[76]毛先晴,欧阳静萍.黄芪多糖对糖尿病KKAy小鼠肝脏脂肪变性的影响[J].中国糖尿病杂志,2008,16(4):233-236
[77]衡先培,张朝春.实用糖尿病手册[M].成都:四川科学技术出版社,2000:144-145
[78]王佳珍,黄小明,陈秀芳.月见草油和多烯康对糖尿病大鼠胰岛素抵抗的治疗作用[J].浙江医学,1998,20(1):24
[79]徐梓辉,周世文,黄林清,等.薏苡仁多糖对实验性2型糖尿病大鼠胰岛素抵抗的 影响[J].中国糖尿病杂志,2002,10(1):44-48
[80]郭洁文,潘竞锵,邱光清,等.荔枝核增强2型糖尿病胰岛素抵抗大鼠胰岛素敏感性作用[J].中国新药杂志,2003,12(7):526-529
[81]徐卫东,林君如,朱姗颖,等.复方苦瓜饮对2型糖尿病大鼠模型胰岛素抵抗的影响[J].江苏大学学报(医学版),2003,13(2):99-100
[82]Vikrant V,Grover JK,Tandon N.Treatment with extracts of momordica charantia and Eugenia jambolana prevents hyper-glycemia and hyperinsulinemia infruct of selfed rats[J].Ethno pharmacol,2001,76(2):139-143
[83]吴正治,李桂云.2型糖尿病胰岛素抵抗中医药研究述评[J].深圳中西医结合杂志,2008,18(1):58-61
[84]黄金海.脑血康对2型糖尿病胰岛素抵抗及超敏C反应蛋白的影响[J].现代中西医结合杂志,2005,14(14):1836-1837
[85]吴迪炯,周鸿,等.杜仲对小鼠胰岛素抵抗干预作用的研究[J].医学研究杂志,2008,37(3):110-112
[86]赵振爱.中药与糖尿病胰岛素抵抗[J].中国误诊学杂志,2007,7(15):3528-3529
[87]曹莉,茅彩萍,顾振纶,等.葛根素对胰岛素抵抗大鼠糖耐量及胰腺组织形态学的影响[J].中国血液流变学杂志,2008,18(1):47-48
[88]宗灿华,田丽梅,等.枸杞多糖对2型糖尿病大鼠胰岛素抵抗及脂联素基因表达的影响[J].中国康复理论与实践,2008,14(6):531-532
[89]王敬,宋光耀,等.银杏叶提取物对高脂胰岛素抵抗大鼠血清瘦素及脂联素的影响[J].北京中医药大学学报.2008,31(1):50-53
[90]刘颖,陆付耳,黄光英,等.丹参对2细胞胰岛素抵抗状态的影响[J].医药导报,2008,27(3):265-267
[91]洪浩,王钦茂,赵帜平,等.丹皮多糖-2对2型糖尿病大鼠的抗糖尿病作用[J].药学通报,2003,38(4):255
[92]沈岚,陆付耳,等.马齿苋对Ⅱ型糖尿病大鼠胰岛素抵抗的影响[J].中国医院药学杂志,2005,25(4):293-295
[93]郑琳颖,潘竞锵,吕俊华,等.白芍总苷增强高脂血症胰岛素抵抗大鼠胰岛素敏感性和降血脂作用研究[J].时珍国医国,2008,19(2):349-351
[94]熊曼琪,林安钟,朱章志,等.加味桃核承气汤对Ⅱ型糖尿病大鼠胰岛素抵抗的影响[J].中国中西医结合杂志,1997,17(3):165-168
[95]陈频,徐向进.复方丹参滴丸对胰岛素抵抗大鼠的保护作用及其机制研究[J].中西医结合心脑血管病杂志,2008,6(5):554-557
[96]周艳.葛根芩连汤对2型糖尿病大鼠的降血糖抗氧化作用[J].中国新医药杂志,2003,2(6):16
[97]付雪艳,董琳.玉液汤对胰岛素抵抗大鼠骨骼肌葡萄糖转运子-4表达的影响[J].时珍国医国药,2008,19(4):921-922
[98]冯锋1,董琳2,张义伟2,于福生3,付雪艳2.玉液汤治疗大鼠胰岛素抵抗实验研究[J].时针国医国药,2008,19(4):945-946
[99]金智生,潘宇清.金匮肾气丸对实验性2型糖尿病胰岛素抵抗大鼠血清TNF-a、Leptin的影响[J].现代中医药,2008,28(3):66-68
[100]钱毅,薛耀明.六味地黄丸对OLETF鼠胰岛素抵抗的影响[J].广东医学,2008,29(3):371-373
[101]程海波,尚文斌,司晓晨.胰敏胶囊阻止高脂膳食诱导大鼠胰岛素抵抗的发生[J].南京中医药大学学报,2003,19(5):281-284
[102]李怡,张前进,李秋贵,等.糖肾胶囊对FFR胰岛素抵抗性与leptin浓度的影响[J].中国实验方剂学杂志,2000,6(1):25-27
[103]李瑾,任志芳.糖康宁对2型糖尿病大鼠胰岛素抵抗的影响[J].江西中医学院学报,2005,17(3):62-63
[104]章小平,方朝晖.参丹健胰丸改善2型糖尿病胰岛素抵抗的机理研究[J].中医药临床杂志,2004,16(6):543-545
[105]申竹芳.金芪降糖片抗糖尿病的药理作用基础[J].国外医学·内分泌分册,2005,24(3):215-216
[106]钱秋海,李玉忠,黄东辉,等.三黄消渴胶囊对Ⅱ型糖尿病模型大鼠胰岛素抵抗的影响[J].山东中医药大学学报,2005,29(5):21-23
[107]王开成,方朝晖.丹蛭降糖胶囊对胰岛素抵抗大鼠脂联素的影响[J].江西中医学院学报,2006,180(2):61
[108]李勇.生芪颗粒对胰岛素抵抗糖尿病大鼠AT1、Ang Ⅱ、ET-1的影响[J].河南中医,2008,28(1):27-30
[109]李勇,刘孟宇,王彦刚.生芪降糖颗粒对胰岛素抵抗鼠的作用及机制研究[J].中国中西医结合杂志,2007,27(5):449
[110]王凌,刘震,李秋贵,等.参地降糖颗粒对胰岛素抵抗的实验研究[J].世界中西医结合杂志,2007,2(4):207.
[111]郭秋慧,李婧,杨静,等.参芪复方合剂对胰岛素抵抗大鼠的治疗作用及机制[J].中国现代医学杂志,2007,17(4):406-409
[112]王东,李敬林,姜良铎,等.糖克煎剂对2型糖尿病模型大鼠胰岛素抵抗的影响[J].中华中医药学刊,2008,26(6):1243-1245
[113]王芬,何华亮.糖耐康对自发性2型糖尿病KKAy小鼠胰岛素信号转导的影响[J].中国实验方剂学杂志,2008,14(1):46-49
[114]苗宇船,张志岗.降脂平肝汤对脂肪肝大鼠胰岛素抵抗的影响[J].山西中医,2008,24(3):45-47
[115]闫爱国,葛争艳.降糖消脂胶囊对2型糖尿病大鼠模型的胰肝脏形态学改变的影响[J].中国中药杂志,2008,33(9):1067-1071
[1]Himsworth.Diabetes mellitus:Its differentiation intoInsulin sen sitive and insulin insensitive type[J].The Lancet,1936,18:127-130
[2]Yalow RS,Berson SA.Immunoassay of endogenous plasma insulin in man[J].Clint Invest,1960,39:l157-1175
[3]De Frantz RA,Tobin JD,Andres R.Glucose clamp technique:a method forquan tifying insulin secretion and resistance[J].Physiol,1979,237(3):214-223
[4]Gerich J,Rizza R,Mandarino L.Assessment of insulin action in humans with Observation on the insulin resistance in non insulin,dependent diabe tes melli tus.In Insulin uptake,[J].Skyler New York,1982,Excerptmedica,74
[5]Reaven GM.Role of insulin in human disease[J].Diabetes,1988,37(12):1595-1607
[6]MP Stern.Diabetes and Cardiovascular disease:The "Common soil" hypothesis [J].Diabetes,1995,44(4):369-374
[7]李秀均.代谢综合征[M].第2版.北京:人民卫生出版社,2007,3:5-7
[8]prokopenko I,McCarthy MI,lindgren CM.TYPE 2 diabetes:new genes,newunder standing[J].Trends Genet,2008,24:613-621
[9]Integrated Management of Cardiovascular RiskReport of a WHO Meeting,2002
[10]Haffner S,Gonzaler C,Miettinen A,et al.A prospective analysis of the Homa model,the Mexico City Diabetes Study.Diabetes Care,1996,19:1138-1141
[11]Jia WP,Xiang WS,Chen L,et al.Epidemiologic study on metabolic symdrome in normal and overweight Chinese in Shanghai[J].Diabetes,1988,37:667-687
[12]Group LC.Insulin resistance:the fundamental trigger of type2 diabe tes.Diabetes Obese metal,1999,1(Supply 1)S:1-7
[13]GM.Role of insulin resistance in human disease[J].Diabetes,1988,15(7):539
[14]Doege H,Boclanski A,Joost HG,et al.The Glut-like family:Anew family of sugar transporters with significant similarity to the glucosetransporters Glut-5[J].Diabetes,2000,49(suppl 1):A30
[15]Mueckler MM,Glucose transporters:Helping sugar slip through the grease [J].Diabetes,1998,47(suppl 1):7
[16]邓尚平.胰岛素免疫原性的临床研究:胰岛素纯度与抗体生成,用药剂量和血糖控制的关系[J].中华内分泌代谢杂志,1987,3:80-82
[17]傅冷西,张小凯,陈红.胰岛素自身抗体与胰岛素抵抗的关系[J].福建医科大学学报,2002,36(1):73-74
[18]姜波,周永列.非胰岛素依赖糖尿病自身抗体和胰岛细胞功能的关系.江西医学检验,2002,20(3):131-133
[19]Chen S,Wiesenthal SR,Lam L,et al.Oleate-induced decrease in hepatocyte insulin binding is mediated by protein kinase C(PKC) activation[J].Diabetes,1999,48(suppl 1):A225
[20]Andrews RC,Walker BR.Glucocorticoids and insulin resistance:old hormones,new targets[J].Clin Sci,1999,96:513-523
[21]张卫卫等.肝硬化胰岛素抵抗及血清生长激素水平的研究[J].世界华人消化杂志,2002,10(10):1180-1183.
[22]Lindsay RS,Lindsay RM,Waddell BJ,et al.Prenatal glucocorticoid exposure leads to offspring hyperglycemia in the rat:studies with the 11βhydroxysteroid dehyrogenase inhibitor carbenoxolone[J].DibeTologia,1996,39:1299-1305
[23]Fishier M,Klein J,Lesser U,et al.Interleukin(IL)6 mRNA Expressionis Stimulated by Insulin,Isoproterenol,Tumor Necrosis Factor Alpha,Growth Hor mone and IL-6 in 3T3-L1 Adiposities[J].Harm Metal Rees,2003,35(3):147-52
[24]罗敏.分子内分泌学(基础与临床)[M].第 版.北京:人民军医出版社.2003;139-140.
[25]Myers,MG,White,MF.The new elements of insulin signaling Insulin receptor substrate -land proteins with SH2 domains[J].Diabetes,1993,42(5):643-650
[26]徐丽君,曾凡鹏,陆付耳,等.补肾通脉方对2型糖尿病大鼠骨骼肌胰岛素受体表达的影响[J].中国医院药学杂志,2003,23(4):201-203
[27]于健,林枫,苏珂,等.2型糖尿病患者正常糖耐量一级亲属红细胞膜胰岛素受体变化及与胰岛素抵抗的相关性[J].中国慢性病预防与控制,2007,15(1):32-33
[28]Shimoyama R,Shelmet JJ,Savage CR,et al.Effects of anti insulin receptoran tibodies(AIRA) on downregulation and turnover ofinsulin rece ptors on cultured Hepatocytes[J].Diabetes,1986,35:2
[29]Mustafa Shin,Elian Kim ET Tetanus,and Nil gun Demurrage Governor,etal.Autoimmune Hypoglycemia in a Type 2 Diabetic Patient with AntiInsulin and Insulin Receptor Antibodies:Response to al[J].Diabetes Care,2004,27(5):1246-1247
[30]Mueckler MM,Glucose transporters:Helping sugar slip through the grease[J].Diabetes,1998,47(suppl 1):7
[31]Taniguchi CM,Emanuelli B,Kahn CR,et al.Critical nodes insig nalling pathways:Insights into insulin action[J].Nat RevMol Cell Bioi,2006,(7):85-96
[32]Luther V,Wojciech W,Lodger K H,et al.Human insulin receptor substrate-2Gene organization and promoter characterization[J].Diabetes,1999,48:1877-1880
[33]Tanti JF,Gremeaus T,Obberghen EV,et al.Insulin receptor substrate 1 isphosphorylated by the serine kinase activity of phosphate dylinositol 3- kinase[J].Biochem J,1994,304:17-21
[34]Lee YH,White MF,et al.Insulin receptor substrate proteins and diabetes[J].Arch Pharm Res,2004,27(3):61-70
[35]White MF.The insulin signaling system andthe IRS proteins[J].Dig betologia,1997,(40):2-17
[36]Bjornholm M,Zierath JR,et al.Insulin signal transduction in hu man skeletal muscle:Identifying the defects in Type Ⅱ diabetes[J].Biochem Soc Trans,2005,33(3):54-57
[37]Amsterdam LL,Gentry W,Jobanputrs S,et al.Anastrazole and oral contrace ptives;A novel treatment for endometriosis[J].Fertil Steril,2004,84(2):300-304
[38]Fatemi HK,Alturki HA,Papanikolaou EG,et al.Successful treatment of an Aggressive recurrent postmenopausal endometriosis with an aroma tize inhibitor.Report Boomed Online.2005,11(4):455-457
[39]Shipper ER,West WJ JR.Successful treatment of severe endometriosis in twoPremenopausal women with an aromas inhibitor.Fertile Steril,2004,81:1395-1398
[40]jianping ye.代谢综合征研究的新进展[J].中国糖尿病杂志,2009,17(2):81-84
[41]Cohen P,Alessi DR,Cross DA.PDK1,one of the missing links ininsulin signal transduction[J].Febs Lett,1997,10(4):3-10
[42]Vanbaesebroeck B,Alessi DR.The PI-3K- PDK connection:more than just a road To PKB[J].Brioche J,2000,346:541-546
[43]Stephens L,Anderson K,Stokoe D,et al.Protein kinase B kinases that mediate phosphatidylinositol 3,4,5trisphos-phate de pendentacti ration of protein kinase B[J].Science,1998,(279):710-714
[44]Duan C,Bauchat JR,Hsieh T.Phosphatidylinositol 3-kinase is required for insulin like growth factor Ⅰ induced vascular smoothmuscle cell pro liferation and migration[J].Circ Res,2000,(86):15-23
[45]魏动,崔巍,王惠芳,等.PI3K/Akt/PKB信号通路与胰岛β细胞功能[J].国际内分泌代谢杂志,2007,27(2):109
[46]Franke TF,Kaplan DR,Cantley LC.P13K:downstream AKTion blocks apo ptosis [J].Cell,1997,88(4):435-437
[47]RajalaMS,Rajala RV,Astley RA,et al.Corneal Cell Survival in Adenovirus Type 19 Infection RequiresPhos phoinositide 32Kinase /Akt /Activationl[J].Virol,2005,79(19):12332-123411
[48]Varma S,Lal BK,Zheng R,et al.Hyperglycemia alters PI3K and Akt signaling and leads to endothelial cell proliferative dysfunction[J].Phy siol Heart Circ Physiol,2005,289(4):H1744-H1751
[49]Ho FM,hin WW,Chen BC,et al.High glucose-inducedapop tosis in human vascular endothelial cells is mediatedthrough NF-kappaB and c-Jun NH2-terminal kinase pathway and p reventedby PI3K/Akt/eNOS pathway[J].Cell Signal,2006,18(3):391-399
[50]James DE.MUNC-ing around with insulin action[J].Clin Invest,2005.115:219-221
[51]张增伟.葡萄糖转运蛋白4在细胞中的生理作用研究进展[J].实用诊断与治疗杂志,2005,19(3):191-193
[52]Began J S,Hendon N,McKee A E,et al.Functional cloning ofTUG as a regulator of GLUT4 glucose transporter trafficking[J].Nature,2003,425(6959):727
[53]Bonnadona RC,Prato SD,Bonora E,et al.Roles of glucose transport and glucose phosphorylation in muscle insulin resistance of NIDDM[J].Diabetes,1996,45:915
[54]Shaw S,Wang X,Red H,et al.High glucose augments the angiogenesisⅡ-induced activation of JAK2 in vascular smooth muscle cells via the polio pathway[J].Boil Chem,2003,278:30634-30641
[55]李震花,张涛,葛志明.高血糖加速动脉粥样硬化的分子生物学机制[J].中国动脉硬化杂志,2006,14(7):633-635
[56]Brownlee MA.The pathbiology of diabetic complications:a unifing me chanism [J].Diabetes.2004,53(Suppl 2):6
[57]Kadowki T.Insights into insulin resistance and type 2 diabetes from knockout mouse models[J].Clin Invest,2000,106(4):459-465
[58]Borden G.Pathogenesis of type 2 diabetes.Insulin resistance[J].Endocrinol Metab ClAn North Am,2001,30(4):801-815
[59]Kelley DE,Williams KV,Price JC,et al.Plasma fatty acids,adiposity,and variance of skeletal muscle insulin resistance in type 2 diabetes mellitus[J].Clint Endocrinal Metab,2001,86(11):5412-5419
[60]Flier is.Clitical conversations:Fat drain,and the regulation of energy balance[J].Diabetes,2005,54(suppl 1):6
[61]Kazuhito Fukui,1 Tsutomu Wada,1 Syota Kagawa,et al.Impact of the Liver-Specific Expression of SHIP2(SH2-Containing Instill 5-Phospha tase 2 onInsulin Signaling and Glucose Metabolism in Mice[J].Diabetes,2005,54(7):1958-1968
[62]Robert K.Hall,Xiao L.Wang,Lena George,et al.Insulin Represses Phos phenol pyruvate Carboxykinase Gene Transcription by Causing the Ra piddisrupt tion of an Active Transcription Complex:A Potentialepigene tic Effect[J].Endocrinol,2007,21(2):550-563
[63]Zong-Chao Ling,Cao Hong-Lie,Claes-G(o|¨)ran(O|¨)stenson,et al.Hypergl ycemia Contributes to Impaired Insulin Response in GK Rat Islets[J].Diabetes,2006, 55(3):590-599
[64]Panarotto D,Remillard P,Bouffard L,et.al.Insulin resistance affects the Regulation of lipoprotein lipase in the postprandial period and in an adipose Tissue-specific manner[J].Ears Clint Invest,2002,32(2):84-92
[65]王涤非,蔡冬梅,蒋丽娟,等.老年胰岛素抵抗小鼠骨骼肌细胞磷脂酰肌醇-3激酶的表达[J].中国现代医学杂志,2006,16(10):1498-1500
[66]Blaak EE,Wolffen buttel BH,Saris WH,et al.Weight reduction and the Impaired plasma-derived free fatty acid oxidation in type 2 diabetes[J].Clint Endocrinal Metab,2001,86(4):1638-1646
[67]Men sink M,Blaak Ivan Beck Meet al.Plasma free fatty acid uptake and Oxidation are already diminished in subjects at high risk for developingtype diabetes[J].Diabetes,2001,50(11):2548-2555
[68]邵致格,孙桂菊,胡曼菁.脂肪分布与胰岛素抵抗[J].现代医学,2005,33(1):63-66
[69]徐炯,李晓惠,顾继安.肿瘤坏死因子α与2型糖尿病关系的探讨[J].2001,24(4):227-229
[70]王东,李敬林.肿瘤坏死因子-α与胰岛素抵抗的研究[J].中医药刊,2003,21(4):560-562
[71]Ruan H,Lodish HF Insulin resistance in adipose tissue directand indireete fleets of tumornecrosis factoralpha[J].Cytokine Growth Factor Rev,2003,14(5):447-455
[72]Ken Ishizuka,Isao Usui,Yukiko Kantian,et al.Chronic TNF-α Treat ment Causes Insulin Resistance via IRS-1 Serine Phosphorylation and SOCS3 Induction In 3T3-L1 Adiposities[J].Endocrinology,2007,3(22):doi:10.1210/en.2006-1702
[73]Hube F,Hauner H.The role of TNF-alpha in human adiposetissue:prevention of weight gain at the expense of insulin resistance[J].Horm Metab Res,1999,31:626-631
[74]Hotamisligit GS.Mechanisms of TNF-alpha-induced insulin resi stance[J].Exp Clin Endocrinol,1999,107:119-125
[75]周红文.脂肪组织的内分泌功能[J].国外医学内分泌学分册,2002,22(1):34-36
[76]RotterV NagaevI,Smith U.Interleukin-6 induces insulin resistance in 3T3-L1 adipocytea and is like IL-8 and TNF-alpha ovel rexpressed in human fat cells from insulin sistant subjects[J].Biol Chem,2003,278(46):45777-45784
[77]Peraldi P,Hotamisligil GS,Burman WA,et al.tumor necrosis factor(TNF)-αinhibits insulin signalling through stimulation of the P55TNF receptor and activation of sphingomyelinase[J].Biol Chem,1996,271:13018.
[78]Paola Di Rocco,Melania Manco,Giuseppina Rosa,et al.Lowered Tumor Necrosis Factor Receptors,but Not Increased Insulin Sensitivity,with Infliximab[J]. Obesity Research,2004,12(4):734-738.
[79]Weyer C,Funshashi T,Tanaka S,et al.Hypoadiponectinemia in obesity and type diabetes:close association with insulin resistance and hyperinsulinemia [J].J Clin Endorinal Metab,2001,86(5):1930-1935.
[80]Yamauchi T,Kamon J,Waki H,et al.The fat-derived hormone adiponec tin reverses insulin resistance associated with both lipoatrophy and obesity[J].Nat Med,2001,7(8):941-946
[81]Hu FB,Dofia A,LI T,et al.Genetic variation at the adiponectin locus and risk of type 2 diabetes in women[J].Diabetes,2004,53(1):209-213
[82]Engeli S,Feldpausch M,Gorzelniak K,et al.Association.between adi ponectin and ediators of inflammationinobesewomen[J].Diabetes,2003,52(4):942-947
[83]Fasshauer M,Kralisch S,Klier M,et al.Adiponectin gene expression and secretion is inhibited by interleukin-6 in 3T3-L1 adipocyte[J].Bio Chem.Biophys Res Commun,2003,301(4):1045-1050
[84]李强翔,钟惠菊.脂肪细胞因子与胰岛素抵抗及2型糖尿病[J].国际生物制品学杂志,2007,30(1):27-30
[85]Kirchgessner TG,Uysal KT,Wiesbrock SM,et al.TNF-α contributes to obesity-related hyperleptinemia by regulatoing ieptin release from adipocytes [J].Clin Invest,1997,100(11):2772-2782.
[86]Kristina W,Ville W,David S,et al.Intracerebroventricular inter leukin-6 treatment decreases body fat in rats[J].Biochem Biophys Res Commun,2002,293(1):560-565.
[87]Senn JJ,Klover PJ,Nowak IA,et al.Suppressor of eytokine signaling-3(SOCS-3),a potential mediator of interleukin-6-dependent insulin resistance in hepatocytes[J].BiolChem,2003,278(16):13740-13746
[88]Rotter V,Nagaev I,Smith U.Interleukin-6(IL-6)induces insulin resistance in 3T3-L1 adipocytes and is,like IL-8 and TNFalpha,overexp ressed in human fatcells from insulin resistant subjects[J].Biol Chem,2003,278(46):45777-45784
[89]Muse ED,Obici S,Bhanot S,et al.Roleofresistinindiet2indwedheaptis Insuunre sistance[J].ClinInvest,2004,114:232-239
[90]Rangwala SM,Rich AS,Rhosdes B,et al.Abnovmalglulosehomeostas is duetochroni chyperresistinemia[J].Diaetes,2004,53:1937-1941
[91]SatohH,NguyernMT,MilesPD,etal.Adenovirusmediatedchornic/hyperresistinemi aOleadstoinvivoinsulinresistanceinnormalrats[J].ClinInvest,2004,114:224-231
[92]FukuharaA,MatsudaM,NishizawaM,etallVisfatin:aproteinsecretedby Vis ceral fatthatmimicstheeffectsofinsulinl[J].Science,2005,307:426-430
[93]Bottcher Y,Teupser.D,Enigk B,et al.Genetic variationinthevis fatgene (PBEF1)and itsrelationto glucose metabo lismandfat depospecificmessen gerri bonucleicaci dexpressionin humans[J].JClEndocrinolMetab,2006,91(7):2725-2731
[94]Vama V,Yao-BorengasserA,RasouliN,et al.Human visfatin expression rela tionship to insulin sensitivity,in tram yocellu lar and inflammation[J].Clin EndocrinolMetab,2007,92(2):666-672
[95]Michalik L,Wahli W.Peroxisome proliferator-activated receptors:three isotypes for amultitude of functions[J].Curr Opin Biotechnol,1999,10(6):564-570
[96]Willson TM,Brown PJ,Sternbach DD,et al.The PPARs:from orphan recap tors to drugdiscovery[J].J Med Chem,2000,43(4):527-550
[97]Iwata M,Haruta T,Usui I,et al.Pioglitazone ameliorates tumor necro sis factor-alpha-inducedinsulin resistance by a mechanism indepen dent of adipogenic activity of peroxisomeproliferator-activated receptor gamma[J].Diabetes,2001,50(5):1083-1092
[98]RA DeFrantz,JD Tobin and R Andres.Glucose clamp technique:a method forQuantifying insulin secretion and resistance[J].Am J Physiol Endoc rinol Metab,1979,237(9):E214-E223
[99]E.W.Krueger,D.E.James,S.P.Bennett,et al.In vivo insulin sensi tivity In the rat determined by euglycemic clamp[J].Am J Physiol Endocrinol Metab,1983,245(7):E1-E7
[100]GM Reaven,RJ Brand,YD Chen,et al.Insulin resistance and insulin secretion is determinants of oral glucose tolerance in normal individual ls[J].Diabetes,1993,42(9):1324-1332
[101]李芳萍.胰岛素抵抗方法体内检测方法[J].国外医学内科学分册,1998,25(3):108-111
[102]张建,华琦.代谢综合症[M].第版.北京:人民卫生出版社,2003:92-98
[103]Haffner S,Gonzaler C,Miettinen A,et al.A prospective analysis of the Homa model,the Mexico City Diabetes Study[J].Diabetes Care,1996,19:1138-1141
[104]李光伟,潘孝仁,LilliojaS,et al.检测人群胰岛素敏感性的一项新指数[J].中华内科杂志,1993,32:656-660
[105]Banerfi MA,Chaiken RL,Gordon D,et al.Dose intra-abdominal adipose Tissue in black,men determine whether NIDDM is insulin resistance or Insulinsensitive [J].Diabetes,1995,44:141-146
[106]Cede Holm J,Libel L.Insulin release and peripheral sensitivity at theoral glucose tolerance test[J].Diabetes Res Clin Pract,1990,10:167-175
[107]Caro JF,Clinical review 26.Insulin resistance in obese and nonobese Man[J].JClin Endocrinol Metab,1991,73:691-695
[108]Katz A,Nambi SS,Mather K,et al.Quantitative insulin sensitivity check index:a simple,accurate method for assessing insulin sensitivity in humans.J Clin Endocrinol Metab,2000,85;2402-2410
[109]Yokoyama H,Emote M,Fujiwara S,et al.Quantitative insulin sensitivity Check index and the reciprocal index of homeostasis model assessment in normal Range weight and moderately obese type 2diabetic patients[J].Diabetes Care,2003,26:2426-2432
[110]Consoli A,Devangelio E.rhiazolidinediones andinflammation[J].Lupus,2005,14(9):749-797
[111]Kanatani Y,Usui I,Ishizuka K,et al.Effects ofpjioaglitazone on suppressor of cytokine signaling 3expression:potential mechanism for its effects on insulin sensitivity and adiponectin expression[J].Diabetes,2007,56(3):795-803
[112]Ialenti A,Grassia G,DI Meglio P,et al.Mechanism of the antiinflamematory effect of thiazolidinediones:relationship with the glucocoticoidpathway[J].Pharmacol,2005,67(5):1620-1628
[113]黄伟,岑均达.非噻唑烷二酮类胰岛素增敏剂的研究进展.中国医药工业杂志,2002,33(6):299-304
[114]Zhu X,Zhou A,Dey A,et al.Ihsroptionof PC1/3 erpression in mice causes Dwarfism and multiple neuroendocrine peptide processing defects.Proc Natl Acad Sci USA,2002,99:10293-10298
[115]战云飞,郑少雄.胰升糖素样肽-1的研究进展[J].国际内分泌杂志,2006,26(4):62-64
[116]Egan JM,Meneilly GS,Elahi D.Effects of 1 mo bolus subcutaneous admini stration of exendin -4in Type 2 Diabetes.Am J Physiol EndocrinolMetab,2003,284:E1072-1079
[1]宫环,张铁梅,李怡,等.不同饲料配方及喂饲方法制备不同胰岛素敏感性大鼠模型的研究[J].中华糖尿病杂志,2005,13(6):455-452.
[2]RA DeFronzo,JD Tobin and R Andres Glucose clamp technique:a method for Quantifying insulin secretion and resistance.Am J Physiol Endocrinol Metab,1979,237(9);E214-E223.
[3]董晓华,张丹参,武海霞.衰老动物模型的研究进展及评价.河北北方学院学报,2004:21(6):41-43
[4]王双,李峻,李秀钧,等.老龄SD大鼠胰岛细胞形态功能研究[J].四川大学学报(医学版),2008,39(2):197-201
[5]王亚楼,刘星.胰岛素增敏剂的临床应用和开发现状[J].中国药物应用与监测,2005,3:21
[6]Spiegelman BM.PPAR:adipogennic regulator and thiazolidioneRecaptor[J].Diabetes,1998,47(4):507
[7]Yu L Y,Li XR,Fang X.Inhibitory effect of totalflavonoids from mulberry tree leaf on small intestinedisaccharidases in diabetic rat s.Zhonghua Nei Fen MiDai Xie Za Zhi.2002;18(4):313-315.Chinese withabst ract in English
[8]刘颖,陆付耳,黄光英,等.丹参对2细胞胰岛素抵抗状态的影响[J].医药导报,2008,27(3):265-267
[9]周丽斌,陈明道,王晓,等.小檗碱对脂肪细胞分化的影响[J].中华医学杂志,2003,83(4):338
[10]Lee YS,Kim WS,Kim KH,et al.Berberine,a naturalplant product,activates AMPactivated protein kinase with beneficial metabolic effects in diabetic and insulinresistant states.Diabetes.2006;55(8):2256-2265
[11]Yang LJ,Yu H Y,Mu YM,et al.Emodin stimulates glucose uptake by Hep G2hepatocyte through activation of PPARγ[J].Zhong Hua Nei Fen Mi Dai Xie Za Zhi.2007;23(3):264-268.Chinese with abst ract in English
[12]万生芳,闻润花.掌叶大黄提取物对实验性2型糖尿病大鼠胰岛素抵抗的实验研究[J].现代中西医结合杂志,2007,16(12):1606
[13]Monzillo LU,Hamdy O,Evaluation of insulin sensitivity in clinical practice and in research settingsl[J].Nutr Rev,2003,61(12):397-412
[14]Ferranninio E,MariA,How to measure insulin sensitivity[J].JHy Pertens,1998,16(7):895-906
[15]Kraegen EW,James DE,Bennett SP,et al In viw insulin sensi tivity in the rat determ fined by euglycem is clamp[J].Am J Physioj,1983,245(1):E1-E7
[16]李晨钟,张素华,舒昌达,等.大鼠正常血糖-高血浆胰岛素钳夹技术[J].重庆医科大学学报,1998,23(3),149-152
[17]罗谋伦,郭欲晓,林志彬,等.大鼠正糖钳实验方法学[J].药学学报,1999,34(4),255-259
[28]尚敬,孙晖,等.清醒状态下大鼠尾动静脉插管高胰岛素-正糖钳夹实验[J].上海交通大学学报(医学版),2006,25(9):968-971
[19]Storlien LH,Oakes ND,Pan DA,et al Syndromes of insulin resistAnce in the rat Inducementby diet and amelioration withbenfluorex[J].Diabetes,1993,42(3):457-462
[20]戚本玲,成蓓,张丽莉,等.罗格列酮对代谢综合征大鼠瘦素和TNF-α的影响[J].中国医院药学杂志,2008,28(6):446-449
[1]高彦彬,周辉,关崧,等.中药糖脂平胶囊干预糖耐量低减的临床研究[J].北京中医药大学学报,2007,30(12):846-849
[2]潘琳 实验性糖尿病病理图谱[M].科学出版社,2007,9:18
[3]Haffner SM,Kennedy E,Gonzalez C,et al.A prospective analysis oft he HOMA model.The Mexico City Diabetes Study[J].DiabetesCare,1996,19(10):1138-1141
[4]Ileen L Whiteman,Han Cho,MorrisJ,Birnbaum.Roleof Akt/Proteinkinase Bin metabolism.TrendsinEndocrinology andMetabolism,2002,13(12):444-451
[5]SternMP.Natural history ofmacrovascular disease in type 2 diabetes[J].Diabetes Care,1999,22(Suppl3):C2-C5
[6]Yu JG,Javorschi S,Hevener AL,etal.The effecto fthiazolidine dionesonplasmaa diponectinlevelsinnormal,obeseantype2diaeticsubjects[J].Diabetes,2002,51(12):2968-2974
[7]黄志强.内分泌代谢疾病[M].天津:天津科学技术出版社,2002:330-331
[8]李秀钧,赵铁耘.脂肪内分泌激素与糖尿病[J].辽宁实用糖尿病杂志,2002,9(2):49-51
[1]Scherer PE,Willians S,Fogliano M,et al.A novel serumprotein similar to Clq,produced exclusivelyin adipocytes[J].J Biol Chem,1995,270(45):2646-2649
[2]YamauchiT,KamonJ,MinokoshiY,etal.Adiponectinstimulatesglucoseutilizationa ndfatty2acidoxidationbyactivatingAMPactivatedproteinkinase[J].NatMed,2002,8:1288-1295
[3]OkamotoY,AritaY,NishidaM,etal.Anadipocytederivedplasmaprotein,adiponectin ,adherestoinjuredvascularwalls[J].HormMetabRes,2000,32:47-50.
[4]何云,崔克勤.血清脂联素水平与2型糖尿病胰岛素抵抗的关系[J].河北医药,2008,30(3):276-277
[5]AritaY,KiharaS,OuchiN,etal.Paradoxicaldecreaseofanadipocytespecificprotei n,adiponectin,inobesity[J].BiochemBiophysResCommun,1999,257:79-83
[6]WinzellMS,NogueirasR,DieguezC,etal.DualactionoAdiponectinoninSulinsecreti onininsulin-resistantmi[J].BiochemBiophysResCommun,2004,321(1):154-60
[7]YamauchiT,KamonJ,WakiH,etal.Globularadiponectinprotectedobobmicefromdiabe tesandApoE-deficientmicefromatherosclerosis[J].JBiolChem,2003,278(4):2461-8
[8]赵运果,刘宏.脂联素与肥胖、2型糖尿病及心血管疾病的相关性[J].医学临床研究,2008,25(5):941-942
[9]HottaK,FunahashiT,AritaY.Plasmaconcentrationsofnoval,adipose-specificprot ein,adiponectin,intype2diabetipatient[J].ArteriosclerThromb VascBiol,2000,20(6):1595-9.
[10]YokoyamaH,EmotoM,MoriK,etal.Plasma adiponectin leveisassociated with insulin stimulated nonoxidativeglucosedisposa[J].Clint endocrine ol Metab,2006,91(1):290-4
[11]Yamauchi T,Kamon J,Waki H,et al.The fat-derived hormone Adi ponectin reverses insulin resistance associated with both lipoatrophy and obesity[J].Nat Med,2001,7:941-946
[12]McGarry JD.W hat if M inkaa ski had been ageusiC An alter nativeangle on diabetes[J].Science 1992 258(5083):766-770
[1]徐炯,李晓惠,顾继安.肿瘤坏死因子α与2型糖尿病关系的探讨[J].2001,24(4):227-229
[2]王东,李敬林.肿瘤坏死因子-α与胰岛素抵抗的研究[J].中医药学刊,2003,21(4):560-562
[3]Ruan H,Lodish HF Insulin resistance in adipose tissue directand indireet effeets of tumor necrosis factor alpha[J].Cytokine Growth Factor Rev.2003,14(5):447-455
[4]Ken Ishizuka,Isao Usui,Yukiko Kantian,et al.Chronic TNF-α Trea tment Causes Insulin Resistance via IRS-1 Serine Phosphorylation and SOCS3 Induction In 3T3-L1 Adiposities.Endocrinology.2007,3(22);doi:10.1210/en.2006-1702
[5]Hube F,Hauner H.The role of TNF-alpha in human adiposetissue:prevention of weight gain at the expense of insulin resistance[J]Horm Metab Res,1999,31:626-631
[6]周红文.脂肪组织的内分泌功能.国外医学内分泌学分册[J].2002,22(1);34-36
[7]RotterV NagaevI,Sm ith U.Interleukin-6 induces insulin resistance in 3T3-L1 adipocytea and is 1 ike IL-8 and TNF-alpha ovelrexpre ssed in human fat cells from insulin-2sistant subjects[J].JBiol Chem,2003,278(46):45777-45784
[8]Peraldi P,Hotamisligil GS,Burman WA,et al.tumor necrosis factor(TNF)-αinhibits insulinsignalling through stimulation of theP55 TNF receptor and activation ofsphingomyelinase[J].J Biol Chem,1996,271:13018
[9]Paola Di Rocco,Melania Manco,Giuseppina Rosa,et al.Lowered Tumor Necrosis Factor Receptors,but Not Increased Insulin Sensitivity,With Infliximab[J].Obesity Research,2004,12(4):734-738
[10]GuptaA,TenS,AnhaltHl Serum levels of soluble tumorn ecrosis factor Al phareceptor 2 are linked to insulin resistance and glucoseintol erancein chil dren[J].JP ediatr Endocrinol Metab,2005,18(1):75-82
[1]Jones PF,Jakubowicz T,Pitossi FJ et al.Molecular cloning and iden tifica
tion of a serine/threonine protein kinase of the secondmessenger subfamily[J].
Proc N at1Aca Sci,1991,88:4171-5
[2]Staal SP,HartleyJW,RoweWP.Isolation of transformingmurineleukemia viruses
from mice with ahigh incidence of spontaneous lymphoma[J].Proc N at1Aca Sci,
1977,74:3065-7
[3]Nicholson KM,Anderson NG1 The protein kinase B/Aktsignalling pathway in
human malignancy[J].Ce11 Signal,2002,14(5):381-95
[4]Cohen P,Alessi DR,Cross DA.PDK1,one of the missing links ininsulin signal
transduction[J].Febs Lett,1997,(410):3-10
[5]Stephens L,Anderson K,Stokoe D,et al.Protein kinase B kinases that mediate
phosphatidylinositol 3,4,5-trisphosphatedependent activation of protein kinase B[J].Science,1998,(279):710-714
[6]Cross DAE,Alessi DR,Cohen P,et al.Inhibition of glycogenSyn thase kinase-3by insulin mediated by protein kinaseB[J].Nature,1995,(378):785-789
[7]Duan C,Bauchat JR,Hsieh T.Phosphatidylinositol 3-kinase is required for insulinlikegrowth factor-I induced vascularsmooth muscle cell prolix feration and migration[J].Circ Res,2000,(86):15-23
[8]SmithU.Impaired (diabetic.)insulinsigna lingandactionoccurin fat ce llslong beforeglucoseintoleranceis insulinresistance initiatedintheadi posetissue IntJObesRetatMetabDisord.2002,26:897-904
[9]SmithU,AxelsenM,CarvalhoE,etal.InsulinsignalingandacTioninfatcells:associ ation swith insulinresistance and type 2diabetes.AnnNYAcad Sci.1999,892:119-126
[1]马学毅.现代糖尿病诊断治疗学,第一版[M].人民军医出版社,2007,9:169
[2]BeesonM,SajanMP,DizonM,etal.ActivationofproteinkinaseCzetabyinsulinandpho sphatidylinosi2to123,4,52(PO4)3isdefectiveinmuscleintypediabetesandimpairedg lucosetolerance:ameliorationbyrosiglitazoneandexercise[J].Diabetes,2003,52:1926
[3]王君,陈祥贵,李鑫等.人类胰岛素信号通路基因表达分析[J].西华大学学报.自然科 学版,2008,27(1)：36-39
[4]StumvollM,GoldsteinBJ,VanHaeftenTW.Type2diabetes:principlesof pathogene sisandtherapy[J].Lancet,2005,365:1333
[5]KirwanJP,DelAguilaLF.Insulinsignalling,exerciseandcellularintegrity[J].Bi ochemSocTrans,2003,31:1281
[6]MeyerMM,LevinK,GrimmsmannT,etal.Troglitazonetreatmentincreasesproteinkina seBphosphorylationinskeletalmuscleofnormoglycemicsubjectsariskforthedevelopm entoftype2diabetes[J].Diabetes,2002,51:2691
[7]Stephens L,Anderson K,Stokoe D,et al.Protein kinase B kinases that mediate phosphatidylinositol 3,4,5-trisphos-phate-dependent activation of protein kinase B[J].Science,1998,(279):710-714
© 2004-2018 中国地质图书馆版权所有 京ICP备05064691号 京公网安备11010802017129号 地址：北京市海淀区学院路29号 邮编：100083 电话：办公室：(+86 10)66554848；文献借阅、咨询服务、科技查新：66554700 |